https://hemeoncbuddy.org/2026-10-02 https://hemeoncbuddy.org/about/2026-09-24 https://hemeoncbuddy.org/algorithms/amyloidosis/2026-09-24 https://hemeoncbuddy.org/algorithms/bladder-mibc/2026-09-24 https://hemeoncbuddy.org/algorithms/bladder-nmibc/2026-09-24 https://hemeoncbuddy.org/algorithms/bone-sarcoma/2026-09-24 https://hemeoncbuddy.org/algorithms/breast-her2-advanced/2026-09-24 https://hemeoncbuddy.org/algorithms/breast-her2-early/2026-09-24 https://hemeoncbuddy.org/algorithms/breast-hrpos-advanced/2026-09-24 https://hemeoncbuddy.org/algorithms/breast-hrpos-early/2026-09-24 https://hemeoncbuddy.org/algorithms/breast-tnbc-advanced/2026-09-24 https://hemeoncbuddy.org/algorithms/breast-tnbc-early/2026-09-24 https://hemeoncbuddy.org/algorithms/ch-aiha/2026-09-24 https://hemeoncbuddy.org/algorithms/ch-aplastic-anemia/2026-09-24 https://hemeoncbuddy.org/algorithms/ch-hemophilia/2026-09-24 https://hemeoncbuddy.org/algorithms/ch-hit/2026-09-24 https://hemeoncbuddy.org/algorithms/ch-iron-deficiency/2026-09-24 https://hemeoncbuddy.org/algorithms/ch-itp/2026-09-24 https://hemeoncbuddy.org/algorithms/ch-sickle-cell/2026-09-24 https://hemeoncbuddy.org/algorithms/ch-ttp/2026-09-24 https://hemeoncbuddy.org/algorithms/ch-vte/2026-09-24 https://hemeoncbuddy.org/algorithms/ch-vwd/2026-09-24 https://hemeoncbuddy.org/algorithms/flowchart-demo/2026-09-24 https://hemeoncbuddy.org/algorithms/gi-anal/2026-09-24 https://hemeoncbuddy.org/algorithms/gi-biliary/2026-09-24 https://hemeoncbuddy.org/algorithms/gi-colorectal/2026-09-24 https://hemeoncbuddy.org/algorithms/gi-esophageal/2026-09-24 https://hemeoncbuddy.org/algorithms/gi-gastric/2026-09-24 https://hemeoncbuddy.org/algorithms/gi-gist/2026-09-24 https://hemeoncbuddy.org/algorithms/gi-hcc/2026-09-24 https://hemeoncbuddy.org/algorithms/gi-net/2026-09-24 https://hemeoncbuddy.org/algorithms/gi-pancreatic/2026-09-24 https://hemeoncbuddy.org/algorithms/gu-prostate/2026-09-24 https://hemeoncbuddy.org/algorithms/gu-rcc/2026-09-24 https://hemeoncbuddy.org/algorithms/gu-testicular/2026-09-24 https://hemeoncbuddy.org/algorithms/gu-urothelial/2026-09-24 https://hemeoncbuddy.org/algorithms/gyn-cervical/2026-09-24 https://hemeoncbuddy.org/algorithms/gyn-endometrial/2026-09-24 https://hemeoncbuddy.org/algorithms/gyn-ovarian/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-all/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-aml/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-cll/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-cml/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-cns-lymphoma/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-dlbcl/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-follicular/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-hairy-cell/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-hodgkin/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-mcl/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-mds/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-mpn/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-myeloma/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-ptcl/2026-09-24 https://hemeoncbuddy.org/algorithms/heme-waldenstrom/2026-09-24 https://hemeoncbuddy.org/algorithms/hn-larynx-hypopharynx/2026-09-24 https://hemeoncbuddy.org/algorithms/hn-nasopharynx/2026-09-24 https://hemeoncbuddy.org/algorithms/hn-oral-cavity/2026-09-24 https://hemeoncbuddy.org/algorithms/hn-oropharynx-p16neg/2026-09-24 https://hemeoncbuddy.org/algorithms/hn-oropharynx-p16pos/2026-09-24 https://hemeoncbuddy.org/algorithms/hn-rm-hnscc/2026-09-24 https://hemeoncbuddy.org/algorithms/hn-salivary/2026-09-24 https://hemeoncbuddy.org/algorithms/2026-09-24 https://hemeoncbuddy.org/algorithms/irae-management/2026-09-24 https://hemeoncbuddy.org/algorithms/myeloma-mgus/2026-09-24 https://hemeoncbuddy.org/algorithms/myeloma-smoldering/2026-09-24 https://hemeoncbuddy.org/algorithms/nsclc-alk/2026-09-24 https://hemeoncbuddy.org/algorithms/nsclc-egfr/2026-09-24 https://hemeoncbuddy.org/algorithms/nsclc-first-line-no-driver/2026-09-24 https://hemeoncbuddy.org/algorithms/nsclc-targetable/2026-09-24 https://hemeoncbuddy.org/algorithms/other-glioblastoma/2026-09-24 https://hemeoncbuddy.org/algorithms/other-sarcoma/2026-09-24 https://hemeoncbuddy.org/algorithms/other-thyroid/2026-09-24 https://hemeoncbuddy.org/algorithms/prostate-localized/2026-09-24 https://hemeoncbuddy.org/algorithms/resectable-nsclc/2026-09-24 https://hemeoncbuddy.org/algorithms/sarcoma-angiosarcoma/2026-09-24 https://hemeoncbuddy.org/algorithms/sclc-first-line/2026-09-24 https://hemeoncbuddy.org/algorithms/sclc-limited/2026-09-24 https://hemeoncbuddy.org/algorithms/skin-melanoma/2026-09-24 https://hemeoncbuddy.org/algorithms/skin-nonmelanoma/2026-09-24 https://hemeoncbuddy.org/algorithms/thymic-tumors/2026-09-24 https://hemeoncbuddy.org/board-review/2026-10-02 https://hemeoncbuddy.org/conferences/2026-09-24 https://hemeoncbuddy.org/conferences/regional/2026-09-24 https://hemeoncbuddy.org/flashcards/2026-09-24 https://hemeoncbuddy.org/flashcards/staging/2026-09-24 https://hemeoncbuddy.org/notes/acute-gvhd/2026-10-02 https://hemeoncbuddy.org/notes/acute-promyelocytic-leukemia-apl/2026-10-02 https://hemeoncbuddy.org/notes/adc/2026-10-02 https://hemeoncbuddy.org/notes/adrenal-tumors/2026-10-02 https://hemeoncbuddy.org/notes/aiha/2026-10-02 https://hemeoncbuddy.org/notes/al-amyloidosis/2026-10-02 https://hemeoncbuddy.org/notes/alk-inhibitors/2026-10-02 https://hemeoncbuddy.org/notes/alkylating-agents/2026-10-02 https://hemeoncbuddy.org/notes/all/2026-10-02 https://hemeoncbuddy.org/notes/allo-hsct/2026-10-02 https://hemeoncbuddy.org/notes/aml-part-1-biology-diagnosis-risk/2026-10-02 https://hemeoncbuddy.org/notes/aml-part-2-treatment-apl-relapse/2026-10-02 https://hemeoncbuddy.org/notes/anal-cancer/2026-10-02 https://hemeoncbuddy.org/notes/anemia/2026-10-02 https://hemeoncbuddy.org/notes/anti-egfr-erb-1-inhibitors/2026-10-02 https://hemeoncbuddy.org/notes/anti-erbb-inhibitors/2026-10-02 https://hemeoncbuddy.org/notes/anticoagulants/2026-10-02 https://hemeoncbuddy.org/notes/antiemetics-cinv/2026-10-02 https://hemeoncbuddy.org/notes/antimetabolites/2026-10-02 https://hemeoncbuddy.org/notes/antimicrotubular-agents/2026-10-02 https://hemeoncbuddy.org/notes/antiphospholipid-syndrome-aps-apls/2026-10-02 https://hemeoncbuddy.org/notes/antitumor-antibiotics/2026-10-02 https://hemeoncbuddy.org/notes/aocd-and-inflammation/2026-10-02 https://hemeoncbuddy.org/notes/b12-and-folate-deficiency/2026-10-02 https://hemeoncbuddy.org/notes/biliary-cancers/2026-10-02 https://hemeoncbuddy.org/notes/bladder-cancer/2026-10-02 https://hemeoncbuddy.org/notes/blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn/2026-10-02 https://hemeoncbuddy.org/notes/bone-marrow-failure-syndromes/2026-10-02 https://hemeoncbuddy.org/notes/bone-sarcomas/2026-10-02 https://hemeoncbuddy.org/notes/braf-and-mek-inhibitors/2026-10-02 https://hemeoncbuddy.org/notes/breast-cancer-part-1-risk-genetics-staging/2026-10-02 https://hemeoncbuddy.org/notes/breast-cancer-part-2-dcis-early-metastatic/2026-10-02 https://hemeoncbuddy.org/notes/burkitt/2026-10-02 https://hemeoncbuddy.org/notes/cancer-in-older-adults/2026-10-02 https://hemeoncbuddy.org/notes/cancer-of-unknown-primary-cup/2026-10-02 https://hemeoncbuddy.org/notes/car-t-and-engager-toxicity/2026-10-02 https://hemeoncbuddy.org/notes/car-t/2026-10-02 https://hemeoncbuddy.org/notes/castleman-disease/2026-10-02 https://hemeoncbuddy.org/notes/cervical-cancer/2026-10-02 https://hemeoncbuddy.org/notes/chemo/2026-10-02 https://hemeoncbuddy.org/notes/chronic-gvhd/2026-10-02 https://hemeoncbuddy.org/notes/chronic-myelomonocytic-leukemia-cmml/2026-10-02 https://hemeoncbuddy.org/notes/clinical-pharmacology/2026-10-02 https://hemeoncbuddy.org/notes/clinical-trials/2026-10-02 https://hemeoncbuddy.org/notes/cll-sll/2026-10-02 https://hemeoncbuddy.org/notes/cml/2026-10-02 https://hemeoncbuddy.org/notes/cns/2026-10-02 https://hemeoncbuddy.org/notes/colorectal-cancer/2026-10-02 https://hemeoncbuddy.org/notes/disorders-of-fibrinolysis/2026-10-02 https://hemeoncbuddy.org/notes/disseminated-intravascular-coagulation-dic/2026-10-02 https://hemeoncbuddy.org/notes/dlbcl/2026-10-02 https://hemeoncbuddy.org/notes/endometrial-cancer/2026-10-02 https://hemeoncbuddy.org/notes/eosinophilia/2026-10-02 https://hemeoncbuddy.org/notes/epidemiology-and-prevention/2026-10-02 https://hemeoncbuddy.org/notes/esophageal-and-gastric-cancer/2026-10-02 https://hemeoncbuddy.org/notes/et/2026-10-02 https://hemeoncbuddy.org/notes/fda-heme-approvals-2022-2026/2026-10-02 https://hemeoncbuddy.org/notes/fl/2026-10-02 https://hemeoncbuddy.org/notes/genetic-testing-for-hereditary-cancer-syndromes/2026-10-02 https://hemeoncbuddy.org/notes/gist-gastrointestinal-stromal-tumor/2026-10-02 https://hemeoncbuddy.org/notes/growth-factors/2026-10-02 https://hemeoncbuddy.org/notes/gynecologic-cancers/2026-10-02 https://hemeoncbuddy.org/notes/gzl/2026-10-02 https://hemeoncbuddy.org/notes/hcc/2026-10-02 https://hemeoncbuddy.org/notes/head-and-neck-cancer-part-1-workup-staging/2026-10-02 https://hemeoncbuddy.org/notes/head-and-neck-cancer-part-2-treatment-npc-cup/2026-10-02 https://hemeoncbuddy.org/notes/hematologic-ihc-reference/2026-10-02 https://hemeoncbuddy.org/notes/hemoglobinopathies/2026-10-02 https://hemeoncbuddy.org/notes/hemolytic-anemias/2026-10-02 https://hemeoncbuddy.org/notes/hemophilia/2026-10-02 https://hemeoncbuddy.org/notes/hemostasis/2026-10-02 https://hemeoncbuddy.org/notes/hereditary-hemolytic-anemias/2026-10-02 https://hemeoncbuddy.org/notes/hereditary-hemorrhagic-telangiectasia-hht/2026-10-02 https://hemeoncbuddy.org/notes/histiocytic-and-dendritic-cell-disorders/2026-10-02 https://hemeoncbuddy.org/notes/hl/2026-10-02 https://hemeoncbuddy.org/notes/hlh/2026-10-02 https://hemeoncbuddy.org/notes/hypercoagulable-states/2026-10-02 https://hemeoncbuddy.org/notes/hypereosinophilic-syndrome-hes/2026-10-02 https://hemeoncbuddy.org/notes/immune-checkpoint-inhibitor-toxicity-iraes/2026-10-02 https://hemeoncbuddy.org/notes/immunology/2026-10-02 https://hemeoncbuddy.org/notes/2026-10-02 https://hemeoncbuddy.org/notes/infections-in-cancer-patients/2026-10-02 https://hemeoncbuddy.org/notes/iron-deficiency-anemia/2026-10-02 https://hemeoncbuddy.org/notes/iron-overload-hemochromatosis/2026-10-02 https://hemeoncbuddy.org/notes/itp/2026-10-02 https://hemeoncbuddy.org/notes/laboratory-techniques/2026-10-02 https://hemeoncbuddy.org/notes/lymphoma-general/2026-10-02 https://hemeoncbuddy.org/notes/malignant-heme-q/2026-10-02 https://hemeoncbuddy.org/notes/mcl/2026-10-02 https://hemeoncbuddy.org/notes/mds/2026-10-02 https://hemeoncbuddy.org/notes/melanoma/2026-10-02 https://hemeoncbuddy.org/notes/mesothelioma/2026-10-02 https://hemeoncbuddy.org/notes/mgus-smm-and-mm/2026-10-02 https://hemeoncbuddy.org/notes/molecular-biology/2026-10-02 https://hemeoncbuddy.org/notes/mpns-sumary/2026-10-02 https://hemeoncbuddy.org/notes/mpns/2026-10-02 https://hemeoncbuddy.org/notes/multikinase-inhibitors/2026-10-02 https://hemeoncbuddy.org/notes/myeloid-growth-factors-esas-tpo-ras/2026-10-02 https://hemeoncbuddy.org/notes/mzl/2026-10-02 https://hemeoncbuddy.org/notes/nets/2026-10-02 https://hemeoncbuddy.org/notes/neutrophil-disorders/2026-10-02 https://hemeoncbuddy.org/notes/non-cutaneous-melanoma/2026-10-02 https://hemeoncbuddy.org/notes/nsclc-part-1-biology-screening-staging/2026-10-02 https://hemeoncbuddy.org/notes/nsclc-part-2-stage-iv-targeted-systemic/2026-10-02 https://hemeoncbuddy.org/notes/other-mpn-mds-mpn/2026-10-02 https://hemeoncbuddy.org/notes/ovarian-cancer/2026-10-02 https://hemeoncbuddy.org/notes/pain-and-symptoms-management/2026-10-02 https://hemeoncbuddy.org/notes/pancreatic-cancer/2026-10-02 https://hemeoncbuddy.org/notes/pcnsl/2026-10-02 https://hemeoncbuddy.org/notes/penile-cancer/2026-10-02 https://hemeoncbuddy.org/notes/platelet-disorders/2026-10-02 https://hemeoncbuddy.org/notes/pmbl/2026-10-02 https://hemeoncbuddy.org/notes/pmf/2026-10-02 https://hemeoncbuddy.org/notes/poems-syndrome/2026-10-02 https://hemeoncbuddy.org/notes/porphyrias/2026-10-02 https://hemeoncbuddy.org/notes/pregnancy-and-hematology/2026-10-02 https://hemeoncbuddy.org/notes/prostate-cancer/2026-10-02 https://hemeoncbuddy.org/notes/ptld/2026-10-02 https://hemeoncbuddy.org/notes/pv/2026-10-02 https://hemeoncbuddy.org/notes/rare-bleeding-disorders/2026-10-02 https://hemeoncbuddy.org/notes/rare-polycythemias-chuvash-pfcp-tempi/2026-10-02 https://hemeoncbuddy.org/notes/rcc/2026-10-02 https://hemeoncbuddy.org/notes/rectal-cancer/2026-10-02 https://hemeoncbuddy.org/notes/salivary-gland-tumors/2026-10-02 https://hemeoncbuddy.org/notes/sarcomas/2026-10-02 https://hemeoncbuddy.org/notes/sclc/2026-10-02 https://hemeoncbuddy.org/notes/sickle-cell-disease/2026-10-02 https://hemeoncbuddy.org/notes/sideroblastic-anemia/2026-10-02 https://hemeoncbuddy.org/notes/soft-tissue-sarcomas/2026-10-02 https://hemeoncbuddy.org/notes/solitary-plasmacytoma-merged/2026-10-02 https://hemeoncbuddy.org/notes/supportive-care/2026-10-02 https://hemeoncbuddy.org/notes/systemic-mastocytosis/2026-10-02 https://hemeoncbuddy.org/notes/t-nk-cell-lymphomas/2026-10-02 https://hemeoncbuddy.org/notes/testicular-cancer/2026-10-02 https://hemeoncbuddy.org/notes/thalassemias/2026-10-02 https://hemeoncbuddy.org/notes/thrombophilias-and-vte-management/2026-10-02 https://hemeoncbuddy.org/notes/thymoma/2026-10-02 https://hemeoncbuddy.org/notes/thyroid-cancers/2026-10-02 https://hemeoncbuddy.org/notes/tkis/2026-10-02 https://hemeoncbuddy.org/notes/tma/2026-10-02 https://hemeoncbuddy.org/notes/topoisomerase-inhibitors/2026-10-02 https://hemeoncbuddy.org/notes/transfusion-medicine/2026-10-02 https://hemeoncbuddy.org/notes/uterine-sarcomas/2026-10-02 https://hemeoncbuddy.org/notes/vaginal-cancer/2026-10-02 https://hemeoncbuddy.org/notes/vegf-inhibitors/2026-10-02 https://hemeoncbuddy.org/notes/von-willebrand-disease-vwd/2026-10-02 https://hemeoncbuddy.org/notes/wm/2026-10-02 https://hemeoncbuddy.org/qbank/2026-09-24 https://hemeoncbuddy.org/stats/2026-10-02 https://hemeoncbuddy.org/trials/2015-ata-thyroid-cancer-guidelines/2026-10-02 https://hemeoncbuddy.org/trials/2l-doce-rami-after-pod-on-chemo-revel-trial/2026-10-02 https://hemeoncbuddy.org/trials/2l-docetaxel-after-pod-on-chemo/2026-10-02 https://hemeoncbuddy.org/trials/2l-lorlatinib-in-ros1-nsclc/2026-10-02 https://hemeoncbuddy.org/trials/2l-lorlatinib-phase-ii-trials/2026-10-02 https://hemeoncbuddy.org/trials/2l-lung-map-trial-rami-pembro/2026-10-02 https://hemeoncbuddy.org/trials/2l-pemetrexed-after-pod-on-chemo/2026-10-02 https://hemeoncbuddy.org/trials/77t-trial/2026-10-02 https://hemeoncbuddy.org/trials/a-brave/2026-10-02 https://hemeoncbuddy.org/trials/aall0232-pediatric-all/2026-10-02 https://hemeoncbuddy.org/trials/aall0232/2026-10-02 https://hemeoncbuddy.org/trials/aall0434-pediatric-all/2026-10-02 https://hemeoncbuddy.org/trials/aall0434/2026-10-02 https://hemeoncbuddy.org/trials/aall1731/2026-10-02 https://hemeoncbuddy.org/trials/aaml1831/2026-10-02 https://hemeoncbuddy.org/trials/aba2/2026-10-02 https://hemeoncbuddy.org/trials/abc-02/2026-10-02 https://hemeoncbuddy.org/trials/abc-06/2026-10-02 https://hemeoncbuddy.org/trials/abcg-8-trial/2026-10-02 https://hemeoncbuddy.org/trials/abcsg-16-trial-salsa-trial/2026-10-02 https://hemeoncbuddy.org/trials/abelacimab-vte-ppx/2026-10-02 https://hemeoncbuddy.org/trials/ablative-rt-dose-response-for-ihcc-tao/2026-10-02 https://hemeoncbuddy.org/trials/accord-12-prodige-2/2026-10-02 https://hemeoncbuddy.org/trials/accord-iii/2026-10-02 https://hemeoncbuddy.org/trials/acns0121-neurocognitive/2026-10-02 https://hemeoncbuddy.org/trials/acns0121/2026-10-02 https://hemeoncbuddy.org/trials/acns0331/2026-10-02 https://hemeoncbuddy.org/trials/acosog-z0011-10-year-update/2026-10-02 https://hemeoncbuddy.org/trials/acosog-z0011/2026-10-02 https://hemeoncbuddy.org/trials/acosog-z6041/2026-10-02 https://hemeoncbuddy.org/trials/acosog-z9001-trial/2026-10-02 https://hemeoncbuddy.org/trials/acse-crizotinib-alk-alcl/2026-10-02 https://hemeoncbuddy.org/trials/acse-pembrolizumab-sarcoma/2026-10-02 https://hemeoncbuddy.org/trials/act-ii-post-hoc-5-year/2026-10-02 https://hemeoncbuddy.org/trials/act-ii/2026-10-02 https://hemeoncbuddy.org/trials/activate/2026-10-02 https://hemeoncbuddy.org/trials/acts-gc/2026-10-02 https://hemeoncbuddy.org/trials/adam-vte/2026-10-02 https://hemeoncbuddy.org/trials/adapt-1-2/2026-10-02 https://hemeoncbuddy.org/trials/adaura-trial-adjuvant-osimertinib/2026-10-02 https://hemeoncbuddy.org/trials/adjuvant-crt-vs-rt-after-cystectomy-zaghloul/2026-10-02 https://hemeoncbuddy.org/trials/adjuvant-ctong1104/2026-10-02 https://hemeoncbuddy.org/trials/adjuvant-durvalumab-lba48-cctg-br-31-trial/2026-10-02 https://hemeoncbuddy.org/trials/adjuvant-radiotherapy-in-mibc-phase-iii/2026-10-02 https://hemeoncbuddy.org/trials/adjuvant-rt-in-extremity-sts-yang-nci/2026-10-02 https://hemeoncbuddy.org/trials/adjuvant-therapy-biliary-tract-cancer-meta-analysis-horgan/2026-10-02 https://hemeoncbuddy.org/trials/admiral-trial-gilteritinib-in-rraml-flt3-itd/2026-10-02 https://hemeoncbuddy.org/trials/adriatic-trial/2026-10-02 https://hemeoncbuddy.org/trials/advantig-302-trial/2026-10-02 https://hemeoncbuddy.org/trials/aegean-trial/2026-10-02 https://hemeoncbuddy.org/trials/aeneas2-trial/2026-10-02 https://hemeoncbuddy.org/trials/aethera/2026-10-02 https://hemeoncbuddy.org/trials/aews0031/2026-10-02 https://hemeoncbuddy.org/trials/afatinib-vs-chemotherapy-in-1st-line/2026-10-02 https://hemeoncbuddy.org/trials/affirm-ahf/2026-10-02 https://hemeoncbuddy.org/trials/affirm-trial/2026-10-02 https://hemeoncbuddy.org/trials/afm13-acimtamig/2026-10-02 https://hemeoncbuddy.org/trials/agave-201/2026-10-02 https://hemeoncbuddy.org/trials/agile/2026-10-02 https://hemeoncbuddy.org/trials/ahl2011-lysa/2026-10-02 https://hemeoncbuddy.org/trials/ahmad-thymic-carcinoma-international-analysis/2026-10-02 https://hemeoncbuddy.org/trials/ahns-ebrt-statement-for-dtc-kiess-2016/2026-10-02 https://hemeoncbuddy.org/trials/ahod0031-cog/2026-10-02 https://hemeoncbuddy.org/trials/ahod0831-cog/2026-10-02 https://hemeoncbuddy.org/trials/ahod1331/2026-10-02 https://hemeoncbuddy.org/trials/aio-0207/2026-10-02 https://hemeoncbuddy.org/trials/aio-krk0116-trial/2026-10-02 https://hemeoncbuddy.org/trials/alcantara/2026-10-02 https://hemeoncbuddy.org/trials/alcanza/2026-10-02 https://hemeoncbuddy.org/trials/alcyone/2026-10-02 https://hemeoncbuddy.org/trials/alemtuzumab-in-t-pll/2026-10-02 https://hemeoncbuddy.org/trials/alex-cns-analysis/2026-10-02 https://hemeoncbuddy.org/trials/alex-trial-alect-vs-crizo/2026-10-02 https://hemeoncbuddy.org/trials/alfa-0701/2026-10-02 https://hemeoncbuddy.org/trials/alienor/2026-10-02 https://hemeoncbuddy.org/trials/alife/2026-10-02 https://hemeoncbuddy.org/trials/alife2/2026-10-02 https://hemeoncbuddy.org/trials/alina/2026-10-02 https://hemeoncbuddy.org/trials/allg-bm12-cast/2026-10-02 https://hemeoncbuddy.org/trials/alliance-a021101/2026-10-02 https://hemeoncbuddy.org/trials/alliance-a041202/2026-10-02 https://hemeoncbuddy.org/trials/alliance-n0574/2026-10-02 https://hemeoncbuddy.org/trials/alliance-n107c/2026-10-02 https://hemeoncbuddy.org/trials/alpine/2026-10-02 https://hemeoncbuddy.org/trials/alsympca/2026-10-02 https://hemeoncbuddy.org/trials/alta-1l-briga-vs-crizo/2026-10-02 https://hemeoncbuddy.org/trials/altair-trial/2026-10-02 https://hemeoncbuddy.org/trials/alxn1210-ahus-311-ravulizumab-ahus/2026-10-02 https://hemeoncbuddy.org/trials/alxn1210-pnh-301-302/2026-10-02 https://hemeoncbuddy.org/trials/amaros/2026-10-02 https://hemeoncbuddy.org/trials/ambassador/2026-10-02 https://hemeoncbuddy.org/trials/amini-2016-adjuvant-crt-vs-rt-salivary/2026-10-02 https://hemeoncbuddy.org/trials/amivantamab-in-egfr-exon-20-mutated-nsclc-brazil-health-syst/2026-10-02 https://hemeoncbuddy.org/trials/aml17-aml19/2026-10-02 https://hemeoncbuddy.org/trials/ampect/2026-10-02 https://hemeoncbuddy.org/trials/amplify-ext/2026-10-02 https://hemeoncbuddy.org/trials/amplify-vte/2026-10-02 https://hemeoncbuddy.org/trials/amplify/2026-10-02 https://hemeoncbuddy.org/trials/anbenitamab-hb1801-neoadjuvant-her2-breast-trial/2026-10-02 https://hemeoncbuddy.org/trials/anbl0532-dose-escalation-analysis/2026-10-02 https://hemeoncbuddy.org/trials/anbl0532/2026-10-02 https://hemeoncbuddy.org/trials/andrews-2001-vs-srs-outcomes/2026-10-02 https://hemeoncbuddy.org/trials/andromeda-final-survival-analysis/2026-10-02 https://hemeoncbuddy.org/trials/andromeda/2026-10-02 https://hemeoncbuddy.org/trials/ang-2001-post-op-rt-risk-factors-time/2026-10-02 https://hemeoncbuddy.org/trials/ang-2010-hpv-oropharyngeal-cancer-prognostic/2026-10-02 https://hemeoncbuddy.org/trials/anhl12p1/2026-10-02 https://hemeoncbuddy.org/trials/anita/2026-10-02 https://hemeoncbuddy.org/trials/annexa-4/2026-10-02 https://hemeoncbuddy.org/trials/announce/2026-10-02 https://hemeoncbuddy.org/trials/anocef-goelams-elderly/2026-10-02 https://hemeoncbuddy.org/trials/anvil-trial/2026-10-02 https://hemeoncbuddy.org/trials/anzntg-01-02-trog-02-01-adjuvant-rt-vs-observation-in-melano/2026-10-02 https://hemeoncbuddy.org/trials/apact/2026-10-02 https://hemeoncbuddy.org/trials/apex/2026-10-02 https://hemeoncbuddy.org/trials/aphinity/2026-10-02 https://hemeoncbuddy.org/trials/apl0406-lo-coco-trial-atra-ato/2026-10-02 https://hemeoncbuddy.org/trials/apml4/2026-10-02 https://hemeoncbuddy.org/trials/aquila/2026-10-02 https://hemeoncbuddy.org/trials/aramis/2026-10-02 https://hemeoncbuddy.org/trials/arasens-trial-docetaxel-adt-darolutamide/2026-10-02 https://hemeoncbuddy.org/trials/archer-1050-trial-dacomitinib-vs-gefitinib/2026-10-02 https://hemeoncbuddy.org/trials/arches/2026-10-02 https://hemeoncbuddy.org/trials/ardeshna-watch-wait-vs-early-r/2026-10-02 https://hemeoncbuddy.org/trials/aren0533/2026-10-02 https://hemeoncbuddy.org/trials/argatroban-hit-arg-911/2026-10-02 https://hemeoncbuddy.org/trials/argentinian-cecog-trial/2026-10-02 https://hemeoncbuddy.org/trials/ariel3/2026-10-02 https://hemeoncbuddy.org/trials/aristotle-rectal-larc/2026-10-02 https://hemeoncbuddy.org/trials/aristotle/2026-10-02 https://hemeoncbuddy.org/trials/arrow-thyroid/2026-10-02 https://hemeoncbuddy.org/trials/arst0331/2026-10-02 https://hemeoncbuddy.org/trials/arst0431/2026-10-02 https://hemeoncbuddy.org/trials/artist-2/2026-10-02 https://hemeoncbuddy.org/trials/artist-trial/2026-10-02 https://hemeoncbuddy.org/trials/asc4first/2026-10-02 https://hemeoncbuddy.org/trials/ascembl/2026-10-02 https://hemeoncbuddy.org/trials/ascend-4-trial-cerit-vs-chemo/2026-10-02 https://hemeoncbuddy.org/trials/ascend-trial-acala-vs-idela-r-or-br-for-rrcll/2026-10-02 https://hemeoncbuddy.org/trials/ascende-rt/2026-10-02 https://hemeoncbuddy.org/trials/ascent-04-keynote-d19/2026-10-02 https://hemeoncbuddy.org/trials/ascent/2026-10-02 https://hemeoncbuddy.org/trials/ascot-jcog1202-5-year-follow-up/2026-10-02 https://hemeoncbuddy.org/trials/ascot-jcog1202/2026-10-02 https://hemeoncbuddy.org/trials/asia-pacific-sorafenib/2026-10-02 https://hemeoncbuddy.org/trials/aspen/2026-10-02 https://hemeoncbuddy.org/trials/aspire/2026-10-02 https://hemeoncbuddy.org/trials/aspre/2026-10-02 https://hemeoncbuddy.org/trials/assure-trial-ecog-acrin-e2805/2026-10-02 https://hemeoncbuddy.org/trials/astec-en-5/2026-10-02 https://hemeoncbuddy.org/trials/astro-bone-metastases-guidelines/2026-10-02 https://hemeoncbuddy.org/trials/astro-guidelines-rt-for-bcc-and-scc-likhacheva/2026-10-02 https://hemeoncbuddy.org/trials/astro-oropharyngeal-cancer-guideline-2017/2026-10-02 https://hemeoncbuddy.org/trials/astro-thoracic-palliative-rt-guidelines/2026-10-02 https://hemeoncbuddy.org/trials/astrum-006-trial/2026-10-02 https://hemeoncbuddy.org/trials/atac-trial/2026-10-02 https://hemeoncbuddy.org/trials/atg-for-gvhd-prophylaxis-kroger/2026-10-02 https://hemeoncbuddy.org/trials/atlas-a-b/2026-10-02 https://hemeoncbuddy.org/trials/atlas-trial/2026-10-02 https://hemeoncbuddy.org/trials/atra-eltrombopag-itp-trial/2026-10-02 https://hemeoncbuddy.org/trials/attend/2026-10-02 https://hemeoncbuddy.org/trials/attlas-trial/2026-10-02 https://hemeoncbuddy.org/trials/attom-trial/2026-10-02 https://hemeoncbuddy.org/trials/attraction-2-trial/2026-10-02 https://hemeoncbuddy.org/trials/attraction-3-trial/2026-10-02 https://hemeoncbuddy.org/trials/attraction-5/2026-10-02 https://hemeoncbuddy.org/trials/aua-astro-adjuvant-salvage-rt-guidelines/2026-10-02 https://hemeoncbuddy.org/trials/augment-101/2026-10-02 https://hemeoncbuddy.org/trials/augment/2026-10-02 https://hemeoncbuddy.org/trials/aurelia/2026-10-02 https://hemeoncbuddy.org/trials/auriga/2026-10-02 https://hemeoncbuddy.org/trials/avaglio/2026-10-02 https://hemeoncbuddy.org/trials/avant/2026-10-02 https://hemeoncbuddy.org/trials/avapritinib-navigator-trial/2026-10-02 https://hemeoncbuddy.org/trials/averroes/2026-10-02 https://hemeoncbuddy.org/trials/axis-trial/2026-10-02 https://hemeoncbuddy.org/trials/axitinib-dose-titration/2026-10-02 https://hemeoncbuddy.org/trials/aza-aml-001/2026-10-02 https://hemeoncbuddy.org/trials/aza-in-high-risk-mds-clinical-trial/2026-10-02 https://hemeoncbuddy.org/trials/b2222/2026-10-02 https://hemeoncbuddy.org/trials/baby-hug/2026-10-02 https://hemeoncbuddy.org/trials/baby-pog-i/2026-10-02 https://hemeoncbuddy.org/trials/basis/2026-10-02 https://hemeoncbuddy.org/trials/bc-2001/2026-10-02 https://hemeoncbuddy.org/trials/bc2001-trial-rt-w-wo-chemo/2026-10-02 https://hemeoncbuddy.org/trials/bcc-treatment-network-meta-analysis-drucker/2026-10-02 https://hemeoncbuddy.org/trials/beacon-crc/2026-10-02 https://hemeoncbuddy.org/trials/beacon-risto-cel-in-scd/2026-10-02 https://hemeoncbuddy.org/trials/beat-meso-etop-13-18/2026-10-02 https://hemeoncbuddy.org/trials/beatcc/2026-10-02 https://hemeoncbuddy.org/trials/belief/2026-10-02 https://hemeoncbuddy.org/trials/believe/2026-10-02 https://hemeoncbuddy.org/trials/belinda/2026-10-02 https://hemeoncbuddy.org/trials/benefit/2026-10-02 https://hemeoncbuddy.org/trials/bep-for-stage-ii-seminoma-garcia-del-muro/2026-10-02 https://hemeoncbuddy.org/trials/bfore-trial/2026-10-02 https://hemeoncbuddy.org/trials/big-1-98-trial/2026-10-02 https://hemeoncbuddy.org/trials/bilcap/2026-10-02 https://hemeoncbuddy.org/trials/birgens-2013-rituximab-prednisolone-vs-prednisolone-warm-aih/2026-10-02 https://hemeoncbuddy.org/trials/bladder-preservation-late-toxicity-efstathiou/2026-10-02 https://hemeoncbuddy.org/trials/blast/2026-10-02 https://hemeoncbuddy.org/trials/bmt-ctn-0201/2026-10-02 https://hemeoncbuddy.org/trials/bmt-ctn-0402/2026-10-02 https://hemeoncbuddy.org/trials/bmt-ctn-0901/2026-10-02 https://hemeoncbuddy.org/trials/bmt-ctn-1301/2026-10-02 https://hemeoncbuddy.org/trials/bmt-ctn-1501/2026-10-02 https://hemeoncbuddy.org/trials/bmt-ctn-1703/2026-10-02 https://hemeoncbuddy.org/trials/bolero-2/2026-10-02 https://hemeoncbuddy.org/trials/bolt/2026-10-02 https://hemeoncbuddy.org/trials/bond-003-cohort-c/2026-10-02 https://hemeoncbuddy.org/trials/bonner/2026-10-02 https://hemeoncbuddy.org/trials/borderline-resectable-pancreatic-cancer-katz/2026-10-02 https://hemeoncbuddy.org/trials/boston/2026-10-02 https://hemeoncbuddy.org/trials/bosutinib-post-2-prior-tkis-nct00261846/2026-10-02 https://hemeoncbuddy.org/trials/bosutinib-post-imatinib-nct00261846/2026-10-02 https://hemeoncbuddy.org/trials/brain-metastases-srs-vs-ha-wbrt-in-tnbc-review/2026-10-02 https://hemeoncbuddy.org/trials/brca-prophylactic-mastectomy-on-brca-ii/2026-10-02 https://hemeoncbuddy.org/trials/brca1-2-hereditary-ovarian-cancer-breast-risk/2026-10-02 https://hemeoncbuddy.org/trials/break-3-trial/2026-10-02 https://hemeoncbuddy.org/trials/breakwater-cohort-3/2026-10-02 https://hemeoncbuddy.org/trials/breakwater/2026-10-02 https://hemeoncbuddy.org/trials/bright-aml-1003/2026-10-02 https://hemeoncbuddy.org/trials/bright-trial/2026-10-02 https://hemeoncbuddy.org/trials/brightline-1-trial/2026-10-02 https://hemeoncbuddy.org/trials/brightness/2026-10-02 https://hemeoncbuddy.org/trials/brim-3-trial/2026-10-02 https://hemeoncbuddy.org/trials/bristol-2007-post-op-rt-maxillary-sinus/2026-10-02 https://hemeoncbuddy.org/trials/british-columbia-active-surveillance-seminoma/2026-10-02 https://hemeoncbuddy.org/trials/british-columbia-rt-rct-ragaz-20yr/2026-10-02 https://hemeoncbuddy.org/trials/brown-imrt-recurrent-ovarian/2026-10-02 https://hemeoncbuddy.org/trials/bruin-cll-313/2026-10-02 https://hemeoncbuddy.org/trials/bruin-cll-321/2026-10-02 https://hemeoncbuddy.org/trials/bruin-cll-322-trial/2026-10-02 https://hemeoncbuddy.org/trials/bruin-phase-1-2/2026-10-02 https://hemeoncbuddy.org/trials/bruin-richter-transformation/2026-10-02 https://hemeoncbuddy.org/trials/bv-monotherapy-salcl/2026-10-02 https://hemeoncbuddy.org/trials/bv-nivolumab-r-r-chl/2026-10-02 https://hemeoncbuddy.org/trials/bv-pivotal-r-r-chl/2026-10-02 https://hemeoncbuddy.org/trials/c-144-01-lifileucel/2026-10-02 https://hemeoncbuddy.org/trials/ca184-024/2026-10-02 https://hemeoncbuddy.org/trials/cabosun-trial/2026-10-02 https://hemeoncbuddy.org/trials/cairo3/2026-10-02 https://hemeoncbuddy.org/trials/cairo6-trial/2026-10-02 https://hemeoncbuddy.org/trials/calgb-100104/2026-10-02 https://hemeoncbuddy.org/trials/calgb-10403/2026-10-02 https://hemeoncbuddy.org/trials/calgb-39808/2026-10-02 https://hemeoncbuddy.org/trials/calgb-40101-trial/2026-10-02 https://hemeoncbuddy.org/trials/calgb-40603-alliance-trial/2026-10-02 https://hemeoncbuddy.org/trials/calgb-50202/2026-10-02 https://hemeoncbuddy.org/trials/calgb-50303/2026-10-02 https://hemeoncbuddy.org/trials/calgb-80803-pet-directed-crt/2026-10-02 https://hemeoncbuddy.org/trials/calgb-8984/2026-10-02 https://hemeoncbuddy.org/trials/calgb-9343/2026-10-02 https://hemeoncbuddy.org/trials/calgb-9344-trial/2026-10-02 https://hemeoncbuddy.org/trials/calgb-9741-trial/2026-10-02 https://hemeoncbuddy.org/trials/calgb-9781/2026-10-02 https://hemeoncbuddy.org/trials/calgb80405-trial/2026-10-02 https://hemeoncbuddy.org/trials/calor-trial/2026-10-02 https://hemeoncbuddy.org/trials/can-2409-trial/2026-10-02 https://hemeoncbuddy.org/trials/canova/2026-10-02 https://hemeoncbuddy.org/trials/cao-aro-aio-04/2026-10-02 https://hemeoncbuddy.org/trials/cao-aro-aio-12/2026-10-02 https://hemeoncbuddy.org/trials/capitello-290-trial/2026-10-02 https://hemeoncbuddy.org/trials/capitello-291/2026-10-02 https://hemeoncbuddy.org/trials/captain-1st/2026-10-02 https://hemeoncbuddy.org/trials/captivate/2026-10-02 https://hemeoncbuddy.org/trials/caravaggio/2026-10-02 https://hemeoncbuddy.org/trials/card/2026-10-02 https://hemeoncbuddy.org/trials/cardinal/2026-10-02 https://hemeoncbuddy.org/trials/cares-009/2026-10-02 https://hemeoncbuddy.org/trials/cares-310-trial/2026-10-02 https://hemeoncbuddy.org/trials/cares-trials-anselamimab/2026-10-02 https://hemeoncbuddy.org/trials/cartitude-1/2026-10-02 https://hemeoncbuddy.org/trials/cartitude-2-cohort-c/2026-10-02 https://hemeoncbuddy.org/trials/cartitude-4/2026-10-02 https://hemeoncbuddy.org/trials/carts-study/2026-10-02 https://hemeoncbuddy.org/trials/caspian/2026-10-02 https://hemeoncbuddy.org/trials/cassiopeia/2026-10-02 https://hemeoncbuddy.org/trials/castor-trial/2026-10-02 https://hemeoncbuddy.org/trials/catnon-eortc-26053-22054/2026-10-02 https://hemeoncbuddy.org/trials/catnon/2026-10-02 https://hemeoncbuddy.org/trials/cc-486-chop-tfh-aitl/2026-10-02 https://hemeoncbuddy.org/trials/ccg-3891-rt-analysis/2026-10-02 https://hemeoncbuddy.org/trials/ccg-3891/2026-10-02 https://hemeoncbuddy.org/trials/ccg-a9961/2026-10-02 https://hemeoncbuddy.org/trials/celestial-trial-cabo-vs-pbo/2026-10-02 https://hemeoncbuddy.org/trials/cepheus/2026-10-02 https://hemeoncbuddy.org/trials/ceteg-noa-09/2026-10-02 https://hemeoncbuddy.org/trials/chaarted-trial-docetaxel/2026-10-02 https://hemeoncbuddy.org/trials/champion/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-017/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-025-trial/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-037-trial/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-040-update/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-040/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-057/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-066-trial/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-067-trial/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-069-trial-ipi-nivo-vs-ipi/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-141-nivo-vs-chemo-in-2nd-line/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-142/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-143/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-204/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-205/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-214-trial/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-227/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-238-trial/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-274-adj-nivo/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-275/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-358-mcc/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-459-nivo-vs-sorafenib-in-1l-hcc/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-498/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-511-trial/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-548/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-577/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-648-5-year-update/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-648/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-649-trial/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-651/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-743-trial-ipi-nivo-for-mesothelioma/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-76k/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-816-trial/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-8hw/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-901/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-914-adj-ipi-nivo/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-9dw/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-9er-trial/2026-10-02 https://hemeoncbuddy.org/trials/checkmate-9la-trial/2026-10-02 https://hemeoncbuddy.org/trials/chemoradiation-for-high-risk-merkel-cell-carcinoma-poulsen/2026-10-02 https://hemeoncbuddy.org/trials/cheng-2003-hd-dex-itp/2026-10-02 https://hemeoncbuddy.org/trials/chhip/2026-10-02 https://hemeoncbuddy.org/trials/chiara-genova-trial-chemo-vs-wart/2026-10-02 https://hemeoncbuddy.org/trials/chips-trial/2026-10-02 https://hemeoncbuddy.org/trials/chisel/2026-10-02 https://hemeoncbuddy.org/trials/chrysalis-2-amivantamab-in-egfr-exon-20-insertion-nsclc/2026-10-02 https://hemeoncbuddy.org/trials/cianchetti-2009-occult-primary-workup/2026-10-02 https://hemeoncbuddy.org/trials/circulate-aio-abcsg-trial/2026-10-02 https://hemeoncbuddy.org/trials/cisplantin-q3wk-vs-q1wk-by-tata-memorial/2026-10-02 https://hemeoncbuddy.org/trials/civic-pod-trial/2026-10-02 https://hemeoncbuddy.org/trials/cladribine-in-hcl/2026-10-02 https://hemeoncbuddy.org/trials/claridhy-trial/2026-10-02 https://hemeoncbuddy.org/trials/clarinet-trial-lancreotide-vs-pbo/2026-10-02 https://hemeoncbuddy.org/trials/classic/2026-10-02 https://hemeoncbuddy.org/trials/clear-trial/2026-10-02 https://hemeoncbuddy.org/trials/cleopatra/2026-10-02 https://hemeoncbuddy.org/trials/climb-scd-121/2026-10-02 https://hemeoncbuddy.org/trials/cll-11-trial-chlorambucil-wt-wo-cd-20i/2026-10-02 https://hemeoncbuddy.org/trials/cll-14-trial-obi-ven-vs-obi-chlorambucil/2026-10-02 https://hemeoncbuddy.org/trials/cll10/2026-10-02 https://hemeoncbuddy.org/trials/cll13-gaia/2026-10-02 https://hemeoncbuddy.org/trials/cll14/2026-10-02 https://hemeoncbuddy.org/trials/cll17/2026-10-02 https://hemeoncbuddy.org/trials/cll6-residuum-final-analysis/2026-10-02 https://hemeoncbuddy.org/trials/cll8/2026-10-02 https://hemeoncbuddy.org/trials/clot/2026-10-02 https://hemeoncbuddy.org/trials/cobrim-trial/2026-10-02 https://hemeoncbuddy.org/trials/cobrra/2026-10-02 https://hemeoncbuddy.org/trials/codebreak-100-trial/2026-10-02 https://hemeoncbuddy.org/trials/codebreak-200/2026-10-02 https://hemeoncbuddy.org/trials/codel-n0577/2026-10-02 https://hemeoncbuddy.org/trials/columbus-ad-trial-eortc-2139-mg/2026-10-02 https://hemeoncbuddy.org/trials/columbus/2026-10-02 https://hemeoncbuddy.org/trials/combi-ad-trial/2026-10-02 https://hemeoncbuddy.org/trials/combi-d-trial/2026-10-02 https://hemeoncbuddy.org/trials/combi-mb/2026-10-02 https://hemeoncbuddy.org/trials/combi-v-trial/2026-10-02 https://hemeoncbuddy.org/trials/combs-2010-vs-linac-srs-vs-fsrt/2026-10-02 https://hemeoncbuddy.org/trials/combs-2015-vs-long-term-srs-fsrt-pooled/2026-10-02 https://hemeoncbuddy.org/trials/comfort-i/2026-10-02 https://hemeoncbuddy.org/trials/comfort-ii/2026-10-02 https://hemeoncbuddy.org/trials/commands/2026-10-02 https://hemeoncbuddy.org/trials/commit-nrg-gi004-swog-s1610/2026-10-02 https://hemeoncbuddy.org/trials/commodore-2/2026-10-02 https://hemeoncbuddy.org/trials/comparz-trial-pazopanib-vs-sunitinib/2026-10-02 https://hemeoncbuddy.org/trials/compete-trial/2026-10-02 https://hemeoncbuddy.org/trials/complement-1/2026-10-02 https://hemeoncbuddy.org/trials/concert-trial/2026-10-02 https://hemeoncbuddy.org/trials/confirm-trial/2026-10-02 https://hemeoncbuddy.org/trials/conko-001/2026-10-02 https://hemeoncbuddy.org/trials/contact-03/2026-10-02 https://hemeoncbuddy.org/trials/convert/2026-10-02 https://hemeoncbuddy.org/trials/coral/2026-10-02 https://hemeoncbuddy.org/trials/correa-apbi-astro-consensus-2017/2026-10-02 https://hemeoncbuddy.org/trials/correct/2026-10-02 https://hemeoncbuddy.org/trials/cosmic-311/2026-10-02 https://hemeoncbuddy.org/trials/cosmic-312-trial-cabo-atezo-vs-sora/2026-10-02 https://hemeoncbuddy.org/trials/cou-aa-301/2026-10-02 https://hemeoncbuddy.org/trials/cou-aa-302/2026-10-02 https://hemeoncbuddy.org/trials/cpx-351-in-saml/2026-10-02 https://hemeoncbuddy.org/trials/cranial-rt-endocrine-deficiency/2026-10-02 https://hemeoncbuddy.org/trials/crash-2/2026-10-02 https://hemeoncbuddy.org/trials/create-x/2026-10-02 https://hemeoncbuddy.org/trials/cristallo-trial/2026-10-02 https://hemeoncbuddy.org/trials/critics/2026-10-02 https://hemeoncbuddy.org/trials/cross-long-term-results/2026-10-02 https://hemeoncbuddy.org/trials/cross-trial/2026-10-02 https://hemeoncbuddy.org/trials/crown-trial/2026-10-02 https://hemeoncbuddy.org/trials/crt-mfolfox/2026-10-02 https://hemeoncbuddy.org/trials/crystal-trial/2026-10-02 https://hemeoncbuddy.org/trials/ctv-margins-for-non-melanoma-skin-cancer-khan/2026-10-02 https://hemeoncbuddy.org/trials/d-alba-gimema-lal2116/2026-10-02 https://hemeoncbuddy.org/trials/d-amico-short-course-adt/2026-10-02 https://hemeoncbuddy.org/trials/d9803/2026-10-02 https://hemeoncbuddy.org/trials/da-epoch-r-burkitt/2026-10-02 https://hemeoncbuddy.org/trials/da-epoch-r-dhl-thl/2026-10-02 https://hemeoncbuddy.org/trials/da-epoch-r-pmbcl/2026-10-02 https://hemeoncbuddy.org/trials/dabrafenib-trametinib-in-rai-refractory-braf-dtc-nct04940052/2026-10-02 https://hemeoncbuddy.org/trials/daco-016/2026-10-02 https://hemeoncbuddy.org/trials/dale-1993-g-csf-scn/2026-10-02 https://hemeoncbuddy.org/trials/danish-dbcg-82b-82c/2026-10-02 https://hemeoncbuddy.org/trials/daromun-l19il2-l19tnf-neoadjuvant/2026-10-02 https://hemeoncbuddy.org/trials/dasatinib-in-cbf-aml/2026-10-02 https://hemeoncbuddy.org/trials/dasision-trial/2026-10-02 https://hemeoncbuddy.org/trials/dbcg-skagen-trial-1/2026-10-02 https://hemeoncbuddy.org/trials/dcvax-l/2026-10-02 https://hemeoncbuddy.org/trials/ddgp-vs-smile/2026-10-02 https://hemeoncbuddy.org/trials/de-escalate-hpv/2026-10-02 https://hemeoncbuddy.org/trials/decide/2026-10-02 https://hemeoncbuddy.org/trials/decision/2026-10-02 https://hemeoncbuddy.org/trials/decog-slt/2026-10-02 https://hemeoncbuddy.org/trials/defi/2026-10-02 https://hemeoncbuddy.org/trials/definitive-rt-for-unresectable-keloids/2026-10-02 https://hemeoncbuddy.org/trials/dellphi-301/2026-10-02 https://hemeoncbuddy.org/trials/dellphi-304/2026-10-02 https://hemeoncbuddy.org/trials/dembo-pelvic-rt-vs-wart/2026-10-02 https://hemeoncbuddy.org/trials/destiny-breast-01-trial/2026-10-02 https://hemeoncbuddy.org/trials/destiny-breast-04/2026-10-02 https://hemeoncbuddy.org/trials/destiny-breast02/2026-10-02 https://hemeoncbuddy.org/trials/destiny-breast03/2026-10-02 https://hemeoncbuddy.org/trials/destiny-breast04/2026-10-02 https://hemeoncbuddy.org/trials/destiny-breast05/2026-10-02 https://hemeoncbuddy.org/trials/destiny-breast06/2026-10-02 https://hemeoncbuddy.org/trials/destiny-breast09/2026-10-02 https://hemeoncbuddy.org/trials/destiny-crc02/2026-10-02 https://hemeoncbuddy.org/trials/destiny-gastric01/2026-10-02 https://hemeoncbuddy.org/trials/destiny-gastric02/2026-10-02 https://hemeoncbuddy.org/trials/destiny-lung02/2026-10-02 https://hemeoncbuddy.org/trials/destiny-pantumor02-endometrial-advanced/2026-10-02 https://hemeoncbuddy.org/trials/destiny-pantumor02/2026-10-02 https://hemeoncbuddy.org/trials/determination/2026-10-02 https://hemeoncbuddy.org/trials/disseminated-ewing-sarcoma-wli/2026-10-02 https://hemeoncbuddy.org/trials/docetaxel-and-estramustine-vs-mitoxantrone/2026-10-02 https://hemeoncbuddy.org/trials/dragon-01-trial/2026-10-02 https://hemeoncbuddy.org/trials/dreamm-7/2026-10-02 https://hemeoncbuddy.org/trials/dreamm-8/2026-10-02 https://hemeoncbuddy.org/trials/dreamseq/2026-10-02 https://hemeoncbuddy.org/trials/duo-e-engot-en10-gog-3084-ago/2026-10-02 https://hemeoncbuddy.org/trials/duo-o-engot-ov46/2026-10-02 https://hemeoncbuddy.org/trials/dupuytren-s-rt-long-term/2026-10-02 https://hemeoncbuddy.org/trials/dupuytren-s-rt-rct/2026-10-02 https://hemeoncbuddy.org/trials/dusseldorf-multiple-myeloma-rt-matuschek/2026-10-02 https://hemeoncbuddy.org/trials/dutch-ckvo-95-04-tme-trial/2026-10-02 https://hemeoncbuddy.org/trials/dutch-d2-dissection-trial/2026-10-02 https://hemeoncbuddy.org/trials/e-1684-trial/2026-10-02 https://hemeoncbuddy.org/trials/e1609-trial/2026-10-02 https://hemeoncbuddy.org/trials/e3a06/2026-10-02 https://hemeoncbuddy.org/trials/e4412/2026-10-02 https://hemeoncbuddy.org/trials/early-palliative-care-rct/2026-10-02 https://hemeoncbuddy.org/trials/ebctcg-bcs-rt-meta-analysis-2011/2026-10-02 https://hemeoncbuddy.org/trials/ebctcg-pmrt-meta-analysis-2014/2026-10-02 https://hemeoncbuddy.org/trials/ebrt-for-medullary-thyroid-cancer-terezakis-2010/2026-10-02 https://hemeoncbuddy.org/trials/echelon-1/2026-10-02 https://hemeoncbuddy.org/trials/echelon-2/2026-10-02 https://hemeoncbuddy.org/trials/ecog-1484-dlbcl-consolidation-rt/2026-10-02 https://hemeoncbuddy.org/trials/ecog-5194/2026-10-02 https://hemeoncbuddy.org/trials/ecog-acrin-e4512-trial/2026-10-02 https://hemeoncbuddy.org/trials/ecog-e1308/2026-10-02 https://hemeoncbuddy.org/trials/ecog-e1910/2026-10-02 https://hemeoncbuddy.org/trials/ecog-e1912/2026-10-02 https://hemeoncbuddy.org/trials/ecog-e3311/2026-10-02 https://hemeoncbuddy.org/trials/ecog-e4201/2026-10-02 https://hemeoncbuddy.org/trials/ecog1900-trial/2026-10-02 https://hemeoncbuddy.org/trials/eculizumab-ahus-c08-002-003/2026-10-02 https://hemeoncbuddy.org/trials/edithal-reni-cel-in-thalassemia/2026-10-02 https://hemeoncbuddy.org/trials/ef-14-ttfields/2026-10-02 https://hemeoncbuddy.org/trials/ef-14/2026-10-02 https://hemeoncbuddy.org/trials/egfr-ex20-2l-mobocertinib/2026-10-02 https://hemeoncbuddy.org/trials/egfr-ex20-chrysalis-trail-2l-amivantamab/2026-10-02 https://hemeoncbuddy.org/trials/egfr-ex20-position20-trial-high-dose-osi/2026-10-02 https://hemeoncbuddy.org/trials/egfr-mutated-nsclc-post-tki-network-meta-analysis-of-regimen/2026-10-02 https://hemeoncbuddy.org/trials/egfr-mutated-nsclc-treatment-sequencing-review/2026-10-02 https://hemeoncbuddy.org/trials/einstein-choice/2026-10-02 https://hemeoncbuddy.org/trials/einstein-dvt/2026-10-02 https://hemeoncbuddy.org/trials/einstein-pe/2026-10-02 https://hemeoncbuddy.org/trials/elara/2026-10-02 https://hemeoncbuddy.org/trials/elate/2026-10-02 https://hemeoncbuddy.org/trials/elevate-lung-nsclc-alk/2026-10-02 https://hemeoncbuddy.org/trials/elevate-rr/2026-10-02 https://hemeoncbuddy.org/trials/elevate-tn/2026-10-02 https://hemeoncbuddy.org/trials/elevate/2026-10-02 https://hemeoncbuddy.org/trials/eliana/2026-10-02 https://hemeoncbuddy.org/trials/eloquent-2/2026-10-02 https://hemeoncbuddy.org/trials/eltrombopag-ist-in-severe-aa/2026-10-02 https://hemeoncbuddy.org/trials/emaa-trial/2026-10-02 https://hemeoncbuddy.org/trials/emapalumab-hlh/2026-10-02 https://hemeoncbuddy.org/trials/embark/2026-10-02 https://hemeoncbuddy.org/trials/embraca/2026-10-02 https://hemeoncbuddy.org/trials/embrace-i/2026-10-02 https://hemeoncbuddy.org/trials/emerald-1/2026-10-02 https://hemeoncbuddy.org/trials/emerald-3-trial/2026-10-02 https://hemeoncbuddy.org/trials/emerald/2026-10-02 https://hemeoncbuddy.org/trials/emilia/2026-10-02 https://hemeoncbuddy.org/trials/emn02-ho95/2026-10-02 https://hemeoncbuddy.org/trials/empower-bcc-1/2026-10-02 https://hemeoncbuddy.org/trials/empower-cervical-1/2026-10-02 https://hemeoncbuddy.org/trials/empower-cscc-1/2026-10-02 https://hemeoncbuddy.org/trials/empower-lung-1/2026-10-02 https://hemeoncbuddy.org/trials/empower-lung-3/2026-10-02 https://hemeoncbuddy.org/trials/enact-trial-enza-vs-active-surveillance/2026-10-02 https://hemeoncbuddy.org/trials/enasidenib-idh2-mutated-mds/2026-10-02 https://hemeoncbuddy.org/trials/enasidenib-r-r-aml-phase-1-2/2026-10-02 https://hemeoncbuddy.org/trials/endeavor/2026-10-02 https://hemeoncbuddy.org/trials/endurance-trial-lenalidomide-maintenance-duration/2026-10-02 https://hemeoncbuddy.org/trials/endurance-trial/2026-10-02 https://hemeoncbuddy.org/trials/energize-t-trial/2026-10-02 https://hemeoncbuddy.org/trials/energize/2026-10-02 https://hemeoncbuddy.org/trials/energy/2026-10-02 https://hemeoncbuddy.org/trials/enestend-trial/2026-10-02 https://hemeoncbuddy.org/trials/engage-af/2026-10-02 https://hemeoncbuddy.org/trials/engot-ov65-keynote-b96/2026-10-02 https://hemeoncbuddy.org/trials/enhance-2026/2026-10-02 https://hemeoncbuddy.org/trials/enhance/2026-10-02 https://hemeoncbuddy.org/trials/enliven/2026-10-02 https://hemeoncbuddy.org/trials/entrectinib-in-ros1-nsclc/2026-10-02 https://hemeoncbuddy.org/trials/envision/2026-10-02 https://hemeoncbuddy.org/trials/enzamet-8-year-outcomes-anzup-1304/2026-10-02 https://hemeoncbuddy.org/trials/enzamet-trial/2026-10-02 https://hemeoncbuddy.org/trials/eol-palliative-rt-trends/2026-10-02 https://hemeoncbuddy.org/trials/eortc-08031/2026-10-02 https://hemeoncbuddy.org/trials/eortc-08993/2026-10-02 https://hemeoncbuddy.org/trials/eortc-18071/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22033-26033-trial/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22033-26033/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22042-26042/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22861/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22863/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22911/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22921/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22922-10925-poortmans/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22922-10925-trial/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22931-rtog-9501-combined-analysis/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22931/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22952-26001-qol/2026-10-02 https://hemeoncbuddy.org/trials/eortc-22952-26001/2026-10-02 https://hemeoncbuddy.org/trials/eortc-24891/2026-10-02 https://hemeoncbuddy.org/trials/eortc-26062-perry-2017/2026-10-02 https://hemeoncbuddy.org/trials/eortc-26951/2026-10-02 https://hemeoncbuddy.org/trials/eortc-26981-22981-stupp-2005/2026-10-02 https://hemeoncbuddy.org/trials/eortc-26981-5-yr-update/2026-10-02 https://hemeoncbuddy.org/trials/eortc-40983/2026-10-02 https://hemeoncbuddy.org/trials/eortc-62005-trial/2026-10-02 https://hemeoncbuddy.org/trials/eortc-62012/2026-10-02 https://hemeoncbuddy.org/trials/eortc-62931/2026-10-02 https://hemeoncbuddy.org/trials/eortc-h10-5-year-update-andre/2026-10-02 https://hemeoncbuddy.org/trials/eortc-h10-f-and-h10-u/2026-10-02 https://hemeoncbuddy.org/trials/eortc-h8-f-and-h8-u/2026-10-02 https://hemeoncbuddy.org/trials/epcat-iii/2026-10-02 https://hemeoncbuddy.org/trials/epcore-fl-1/2026-10-02 https://hemeoncbuddy.org/trials/epcore-nhl-1/2026-10-02 https://hemeoncbuddy.org/trials/epic-terminated/2026-10-02 https://hemeoncbuddy.org/trials/erdafitinib-trial/2026-10-02 https://hemeoncbuddy.org/trials/eribulin-vs-dacarbazine-liposarcoma/2026-10-02 https://hemeoncbuddy.org/trials/erivance-bcc/2026-10-02 https://hemeoncbuddy.org/trials/erlotinib-bevacizumab-trials/2026-10-02 https://hemeoncbuddy.org/trials/erlotinib-vs-chemotherapy-in-1st-line/2026-10-02 https://hemeoncbuddy.org/trials/erspc-23-year-follow-up/2026-10-02 https://hemeoncbuddy.org/trials/esopec/2026-10-02 https://hemeoncbuddy.org/trials/espac-1/2026-10-02 https://hemeoncbuddy.org/trials/espac-3/2026-10-02 https://hemeoncbuddy.org/trials/espac-4/2026-10-02 https://hemeoncbuddy.org/trials/espac-5f/2026-10-02 https://hemeoncbuddy.org/trials/estro-eortc-oligometastatic-consensus/2026-10-02 https://hemeoncbuddy.org/trials/euramos-1-good-response/2026-10-02 https://hemeoncbuddy.org/trials/euramos-1-poor-response-mapie/2026-10-02 https://hemeoncbuddy.org/trials/euro-e-w-i-n-g-99-ewing-2008-hdct/2026-10-02 https://hemeoncbuddy.org/trials/euro-ski/2026-10-02 https://hemeoncbuddy.org/trials/euronet-phl-c1/2026-10-02 https://hemeoncbuddy.org/trials/euronet-phl-lp1/2026-10-02 https://hemeoncbuddy.org/trials/european-mcl-network-elderly/2026-10-02 https://hemeoncbuddy.org/trials/ev-301-trial-enfortumab-vedotin/2026-10-02 https://hemeoncbuddy.org/trials/ev-302-keynote-a39/2026-10-02 https://hemeoncbuddy.org/trials/evan/2026-10-02 https://hemeoncbuddy.org/trials/evoke-01-trial/2026-10-02 https://hemeoncbuddy.org/trials/evolution-trial/2026-10-02 https://hemeoncbuddy.org/trials/exa-cel-in-children-climb-thal-141-scd-151/2026-10-02 https://hemeoncbuddy.org/trials/exalt3/2026-10-02 https://hemeoncbuddy.org/trials/exam/2026-10-02 https://hemeoncbuddy.org/trials/excaliber-rrmm/2026-10-02 https://hemeoncbuddy.org/trials/exist-2-trial/2026-10-02 https://hemeoncbuddy.org/trials/expert-consensus-pre-op-rt-for-retroperitoneal-sarcoma-baldi/2026-10-02 https://hemeoncbuddy.org/trials/extend/2026-10-02 https://hemeoncbuddy.org/trials/extended-endocrine-therapy-premenopausal-cohort/2026-10-02 https://hemeoncbuddy.org/trials/extenet/2026-10-02 https://hemeoncbuddy.org/trials/extentorch-trial/2026-10-02 https://hemeoncbuddy.org/trials/extramedullary-plasmacytoma-alexiou/2026-10-02 https://hemeoncbuddy.org/trials/extreme-trial-cis-5fu-cetuximab/2026-10-02 https://hemeoncbuddy.org/trials/face-trial/2026-10-02 https://hemeoncbuddy.org/trials/fair-hf/2026-10-02 https://hemeoncbuddy.org/trials/fast-forward/2026-10-02 https://hemeoncbuddy.org/trials/felix/2026-10-02 https://hemeoncbuddy.org/trials/ffcd-9102/2026-10-02 https://hemeoncbuddy.org/trials/fight-202/2026-10-02 https://hemeoncbuddy.org/trials/fight-302-trial/2026-10-02 https://hemeoncbuddy.org/trials/fight/2026-10-02 https://hemeoncbuddy.org/trials/find/2026-10-02 https://hemeoncbuddy.org/trials/fire-trial-final-analysis/2026-10-02 https://hemeoncbuddy.org/trials/firm-act/2026-10-02 https://hemeoncbuddy.org/trials/first-trial-final-analysis/2026-10-02 https://hemeoncbuddy.org/trials/fit/2026-10-02 https://hemeoncbuddy.org/trials/flair/2026-10-02 https://hemeoncbuddy.org/trials/flaura-cns-analysis/2026-10-02 https://hemeoncbuddy.org/trials/flaura-trial/2026-10-02 https://hemeoncbuddy.org/trials/flaura2/2026-10-02 https://hemeoncbuddy.org/trials/flickinger-2003-meningioma-srs-complications/2026-10-02 https://hemeoncbuddy.org/trials/flot4/2026-10-02 https://hemeoncbuddy.org/trials/flyer-trial/2026-10-02 https://hemeoncbuddy.org/trials/folfiri-plus-bev-in-mcrc/2026-10-02 https://hemeoncbuddy.org/trials/folfiri-vs-5fu-in-metastatic-crc/2026-10-02 https://hemeoncbuddy.org/trials/folfirinox-for-metastatic-pancreatic-cancer-accord-11/2026-10-02 https://hemeoncbuddy.org/trials/folfirinox-meta-analysis-for-lapc-suker/2026-10-02 https://hemeoncbuddy.org/trials/folfox-vs-5-fu-in-metastatic-crc/2026-10-02 https://hemeoncbuddy.org/trials/forquer-seer-thymoma/2026-10-02 https://hemeoncbuddy.org/trials/fort-follicular-lymphoma-radiotherapy/2026-10-02 https://hemeoncbuddy.org/trials/forte-trial/2026-10-02 https://hemeoncbuddy.org/trials/forum/2026-10-02 https://hemeoncbuddy.org/trials/foxtrot-trial/2026-10-02 https://hemeoncbuddy.org/trials/fresco-trial-fruquintinib-vs-pbo/2026-10-02 https://hemeoncbuddy.org/trials/fried-rt-timing-systematic-review/2026-10-02 https://hemeoncbuddy.org/trials/frontier4-trial/2026-10-02 https://hemeoncbuddy.org/trials/frontmind-trial/2026-10-02 https://hemeoncbuddy.org/trials/fushimi-cab-ar-sdc/2026-10-02 https://hemeoncbuddy.org/trials/gadolin/2026-10-02 https://hemeoncbuddy.org/trials/gallium/2026-10-02 https://hemeoncbuddy.org/trials/galloway-2015-sccup-management-review/2026-10-02 https://hemeoncbuddy.org/trials/garnet/2026-10-02 https://hemeoncbuddy.org/trials/gastric-lymph-node-contouring-atlas/2026-10-02 https://hemeoncbuddy.org/trials/gastrointestinal-tumor-study-group-9173/2026-10-02 https://hemeoncbuddy.org/trials/gec-estro/2026-10-02 https://hemeoncbuddy.org/trials/geddis-trial-doxorubicin-vs-gem-docetaxel-in-soft-tissue-sar/2026-10-02 https://hemeoncbuddy.org/trials/gefitinib-vs-chemotherapy-in-1st-line/2026-10-02 https://hemeoncbuddy.org/trials/geicam-2003-11-ciboma-2004-01-trial/2026-10-02 https://hemeoncbuddy.org/trials/gela-lnh-03-2b/2026-10-02 https://hemeoncbuddy.org/trials/gem-cis-imrt-vs/2026-10-02 https://hemeoncbuddy.org/trials/gemcis-vs-mvac-in-advanced-bladder-ca/2026-10-02 https://hemeoncbuddy.org/trials/gemcitabine-vs-5-fu-trial/2026-10-02 https://hemeoncbuddy.org/trials/gener8-1/2026-10-02 https://hemeoncbuddy.org/trials/geometry-mono-1/2026-10-02 https://hemeoncbuddy.org/trials/gercor-retrospective-huguet/2026-10-02 https://hemeoncbuddy.org/trials/german-aro-96-02/2026-10-02 https://hemeoncbuddy.org/trials/german-rectal-cancer-trial/2026-10-02 https://hemeoncbuddy.org/trials/german-stage-i-seminoma-dose-study-classen/2026-10-02 https://hemeoncbuddy.org/trials/german-trial-stahl-scc-surgery-vs-definitive-crt/2026-10-02 https://hemeoncbuddy.org/trials/getug-afu-16/2026-10-02 https://hemeoncbuddy.org/trials/getug-afu-18-trial/2026-10-02 https://hemeoncbuddy.org/trials/ghsg-hd10-long-term-update-sasse/2026-10-02 https://hemeoncbuddy.org/trials/ghsg-hd10/2026-10-02 https://hemeoncbuddy.org/trials/ghsg-hd4/2026-10-02 https://hemeoncbuddy.org/trials/ghsg-hd7/2026-10-02 https://hemeoncbuddy.org/trials/gimema-lal1205/2026-10-02 https://hemeoncbuddy.org/trials/gimema-lal2317/2026-10-02 https://hemeoncbuddy.org/trials/gitsg-trial/2026-10-02 https://hemeoncbuddy.org/trials/glow-cll/2026-10-02 https://hemeoncbuddy.org/trials/glow/2026-10-02 https://hemeoncbuddy.org/trials/go29365-pola-br/2026-10-02 https://hemeoncbuddy.org/trials/gog-109/2026-10-02 https://hemeoncbuddy.org/trials/gog-120/2026-10-02 https://hemeoncbuddy.org/trials/gog-122/2026-10-02 https://hemeoncbuddy.org/trials/gog-205/2026-10-02 https://hemeoncbuddy.org/trials/gog-213/2026-10-02 https://hemeoncbuddy.org/trials/gog-218/2026-10-02 https://hemeoncbuddy.org/trials/gog-240/2026-10-02 https://hemeoncbuddy.org/trials/gog-249/2026-10-02 https://hemeoncbuddy.org/trials/gog-258/2026-10-02 https://hemeoncbuddy.org/trials/gog-281-logs/2026-10-02 https://hemeoncbuddy.org/trials/gog-3026-gcig-maintenance-trial/2026-10-02 https://hemeoncbuddy.org/trials/gog-36/2026-10-02 https://hemeoncbuddy.org/trials/gog-37/2026-10-02 https://hemeoncbuddy.org/trials/gog-7602-wai-vs-ip-32-p/2026-10-02 https://hemeoncbuddy.org/trials/gog-88/2026-10-02 https://hemeoncbuddy.org/trials/gog-92/2026-10-02 https://hemeoncbuddy.org/trials/gog-99/2026-10-02 https://hemeoncbuddy.org/trials/goldsmith-1994-ucsf-meningioma-rt/2026-10-02 https://hemeoncbuddy.org/trials/golp-zsab-neogolp/2026-10-02 https://hemeoncbuddy.org/trials/gondi-2010-ha-wbrt-technique/2026-10-02 https://hemeoncbuddy.org/trials/goodman-capecitabine-vs-5-fu-imrt/2026-10-02 https://hemeoncbuddy.org/trials/gortec-2000-01-trial-tpf-vs-pf/2026-10-02 https://hemeoncbuddy.org/trials/goya/2026-10-02 https://hemeoncbuddy.org/trials/graall-2003-2005/2026-10-02 https://hemeoncbuddy.org/trials/graall-2014/2026-10-02 https://hemeoncbuddy.org/trials/grant-2014-high-dose-srs-pituitary-adenoma/2026-10-02 https://hemeoncbuddy.org/trials/greccar-6/2026-10-02 https://hemeoncbuddy.org/trials/griffin-trial/2026-10-02 https://hemeoncbuddy.org/trials/groinss-v-i/2026-10-02 https://hemeoncbuddy.org/trials/groinss-v-ii/2026-10-02 https://hemeoncbuddy.org/trials/h10-eortc-lysa-fil/2026-10-02 https://hemeoncbuddy.org/trials/haplo-gvhd-prophylaxis-low-dose-atg-ptcy-vs-atg-vs-ptcy/2026-10-02 https://hemeoncbuddy.org/trials/harmoni-6/2026-10-02 https://hemeoncbuddy.org/trials/harmoni-a-ivonescimab/2026-10-02 https://hemeoncbuddy.org/trials/harmoni-a-trial/2026-10-02 https://hemeoncbuddy.org/trials/harmoni-trial/2026-10-02 https://hemeoncbuddy.org/trials/harmony/2026-10-02 https://hemeoncbuddy.org/trials/harvard-mesothelioma-trimodality/2026-10-02 https://hemeoncbuddy.org/trials/harvard/2026-10-02 https://hemeoncbuddy.org/trials/haven-1-trial-emicizumab-with-inhibitor-12y-o/2026-10-02 https://hemeoncbuddy.org/trials/haven-2-trial-emicizumab-with-inhibitor-12y-o/2026-10-02 https://hemeoncbuddy.org/trials/haven-3-trial-emicizumab-no-inhibitor-12y-o/2026-10-02 https://hemeoncbuddy.org/trials/haven-4/2026-10-02 https://hemeoncbuddy.org/trials/hct-in-50-75yo-mds/2026-10-02 https://hemeoncbuddy.org/trials/hd-il-2-meta-analysis/2026-10-02 https://hemeoncbuddy.org/trials/hd-mvac-vs-classic-mvac-in-advanced-urothelial-tract-tumors/2026-10-02 https://hemeoncbuddy.org/trials/hd10-ghsg/2026-10-02 https://hemeoncbuddy.org/trials/hd11-ghsg/2026-10-02 https://hemeoncbuddy.org/trials/hd13-ghsg/2026-10-02 https://hemeoncbuddy.org/trials/hd14-ghsg/2026-10-02 https://hemeoncbuddy.org/trials/hd15-ghsg/2026-10-02 https://hemeoncbuddy.org/trials/hd17-ghsg/2026-10-02 https://hemeoncbuddy.org/trials/hd18-ghsg/2026-10-02 https://hemeoncbuddy.org/trials/hd21-ghsg/2026-10-02 https://hemeoncbuddy.org/trials/helios/2026-10-02 https://hemeoncbuddy.org/trials/hematological-ici-toxicity-pharmacovigilance-study/2026-10-02 https://hemeoncbuddy.org/trials/hematological-immune-related-adverse-events-from-icis-manage/2026-10-02 https://hemeoncbuddy.org/trials/her2-uterine-serous-carcinoma/2026-10-02 https://hemeoncbuddy.org/trials/her2climb-05/2026-10-02 https://hemeoncbuddy.org/trials/her2climb-bm-analysis/2026-10-02 https://hemeoncbuddy.org/trials/hercules/2026-10-02 https://hemeoncbuddy.org/trials/herizon-gea-01-phase-ib-ii/2026-10-02 https://hemeoncbuddy.org/trials/herizon-gea-01/2026-10-02 https://hemeoncbuddy.org/trials/hero-trial/2026-10-02 https://hemeoncbuddy.org/trials/hgb-206/2026-10-02 https://hemeoncbuddy.org/trials/hgb-207-212/2026-10-02 https://hemeoncbuddy.org/trials/himalaya-trial-tremelimumab-plus-durvalumab-in-unresectable/2026-10-02 https://hemeoncbuddy.org/trials/hlh-2004/2026-10-02 https://hemeoncbuddy.org/trials/hlx11-pertuzumab-biosimilar/2026-10-02 https://hemeoncbuddy.org/trials/ho-rt-prophylaxis-meta-analysis/2026-10-02 https://hemeoncbuddy.org/trials/ho-rt-prophylaxis-multicenter/2026-10-02 https://hemeoncbuddy.org/trials/hog-lun-01-24/2026-10-02 https://hemeoncbuddy.org/trials/hokusai-vte-cancer/2026-10-02 https://hemeoncbuddy.org/trials/hokusai-vte/2026-10-02 https://hemeoncbuddy.org/trials/hope-b/2026-10-02 https://hemeoncbuddy.org/trials/hope-kids-2-trial/2026-10-02 https://hemeoncbuddy.org/trials/hope/2026-10-02 https://hemeoncbuddy.org/trials/horizon-breast01-trial/2026-10-02 https://hemeoncbuddy.org/trials/hydra/2026-10-02 https://hemeoncbuddy.org/trials/hypo-rt-pc/2026-10-02 https://hemeoncbuddy.org/trials/hypofractionated-proton-rt-for-hcc-icca-hong/2026-10-02 https://hemeoncbuddy.org/trials/hypofractionation-for-malignant-melanoma-chang-mdacc/2026-10-02 https://hemeoncbuddy.org/trials/hypog-01/2026-10-02 https://hemeoncbuddy.org/trials/iaea-trial-roa-2015/2026-10-02 https://hemeoncbuddy.org/trials/ibcsg-23-01/2026-10-02 https://hemeoncbuddy.org/trials/ibis-i/2026-10-02 https://hemeoncbuddy.org/trials/ibis-ii/2026-10-02 https://hemeoncbuddy.org/trials/icaria-mm/2026-10-02 https://hemeoncbuddy.org/trials/icon-7/2026-10-02 https://hemeoncbuddy.org/trials/icud-eau-muscle-invasive-bladder-cancer-guidelines-gakis/2026-10-02 https://hemeoncbuddy.org/trials/idea-collaboration/2026-10-02 https://hemeoncbuddy.org/trials/ideal-boog-2006-05-trial/2026-10-02 https://hemeoncbuddy.org/trials/idhentify/2026-10-02 https://hemeoncbuddy.org/trials/ielsg-10-primary-testicular-dlbcl-vitolo/2026-10-02 https://hemeoncbuddy.org/trials/ielsg-19/2026-10-02 https://hemeoncbuddy.org/trials/ielsg-32-consolidation/2026-10-02 https://hemeoncbuddy.org/trials/ielsg-32-induction/2026-10-02 https://hemeoncbuddy.org/trials/ielsg-orbital-malt-lymphoma-wirth/2026-10-02 https://hemeoncbuddy.org/trials/ielsg37/2026-10-02 https://hemeoncbuddy.org/trials/ies-trial/2026-10-02 https://hemeoncbuddy.org/trials/ifm-2005-02/2026-10-02 https://hemeoncbuddy.org/trials/ifm-2009/2026-10-02 https://hemeoncbuddy.org/trials/ifm2009-trial/2026-10-02 https://hemeoncbuddy.org/trials/ifn-gamma-cgd/2026-10-02 https://hemeoncbuddy.org/trials/ikema/2026-10-02 https://hemeoncbuddy.org/trials/illuminate/2026-10-02 https://hemeoncbuddy.org/trials/ilrog-follicular-lymphoma-rt-guidelines-brady/2026-10-02 https://hemeoncbuddy.org/trials/ilrog-multiple-myeloma-rt-guidelines-tsang/2026-10-02 https://hemeoncbuddy.org/trials/imatinib-dfsp/2026-10-02 https://hemeoncbuddy.org/trials/imbrave-150-atezo-bev-vs-sora/2026-10-02 https://hemeoncbuddy.org/trials/imbrave050/2026-10-02 https://hemeoncbuddy.org/trials/imdc-analysis/2026-10-02 https://hemeoncbuddy.org/trials/imerge/2026-10-02 https://hemeoncbuddy.org/trials/imforte/2026-10-02 https://hemeoncbuddy.org/trials/immotion151-trial/2026-10-02 https://hemeoncbuddy.org/trials/immuned-trial/2026-10-02 https://hemeoncbuddy.org/trials/impassion031/2026-10-02 https://hemeoncbuddy.org/trials/impassion130/2026-10-02 https://hemeoncbuddy.org/trials/import-low/2026-10-02 https://hemeoncbuddy.org/trials/impower-010-trial-adj-atezo/2026-10-02 https://hemeoncbuddy.org/trials/impower-133/2026-10-02 https://hemeoncbuddy.org/trials/impower110-trial/2026-10-02 https://hemeoncbuddy.org/trials/impower150/2026-10-02 https://hemeoncbuddy.org/trials/imprint/2026-10-02 https://hemeoncbuddy.org/trials/impt-vs-imrt-nsclc-dosimetry/2026-10-02 https://hemeoncbuddy.org/trials/impt-vs-imrt-oropharynx/2026-10-02 https://hemeoncbuddy.org/trials/imroz/2026-10-02 https://hemeoncbuddy.org/trials/imrt-vs-conventional-ebrt-for-sts-folkert-mskcc/2026-10-02 https://hemeoncbuddy.org/trials/imrt-vs-conventional-neuroblastoma-rt/2026-10-02 https://hemeoncbuddy.org/trials/imspire-150-trial/2026-10-02 https://hemeoncbuddy.org/trials/imvigor210-atezo-in-cis-ineligble/2026-10-02 https://hemeoncbuddy.org/trials/inavo120/2026-10-02 https://hemeoncbuddy.org/trials/2026-10-02 https://hemeoncbuddy.org/trials/indigo/2026-10-02 https://hemeoncbuddy.org/trials/inmind/2026-10-02 https://hemeoncbuddy.org/trials/innovate/2026-10-02 https://hemeoncbuddy.org/trials/innovatv-301/2026-10-02 https://hemeoncbuddy.org/trials/ino-vate/2026-10-02 https://hemeoncbuddy.org/trials/int-0091-iess-iii/2026-10-02 https://hemeoncbuddy.org/trials/int-0096/2026-10-02 https://hemeoncbuddy.org/trials/int-0099/2026-10-02 https://hemeoncbuddy.org/trials/int-0123-rtog-94-05-dose-escalation/2026-10-02 https://hemeoncbuddy.org/trials/int-0154/2026-10-02 https://hemeoncbuddy.org/trials/inter-b-nhl-ritux-2010/2026-10-02 https://hemeoncbuddy.org/trials/interaact/2026-10-02 https://hemeoncbuddy.org/trials/intergroup-0099/2026-10-02 https://hemeoncbuddy.org/trials/intergroup-0116/2026-10-02 https://hemeoncbuddy.org/trials/intergroup-0139/2026-10-02 https://hemeoncbuddy.org/trials/intergroup-0160/2026-10-02 https://hemeoncbuddy.org/trials/intergroup-eortc-62024-trial/2026-10-02 https://hemeoncbuddy.org/trials/intergroup-rtog-ecog/2026-10-02 https://hemeoncbuddy.org/trials/interlace/2026-10-02 https://hemeoncbuddy.org/trials/intermittent-androgen-suppression/2026-10-02 https://hemeoncbuddy.org/trials/international-watch-and-wait-database-iwwd/2026-10-02 https://hemeoncbuddy.org/trials/intrago-ii-trial/2026-10-02 https://hemeoncbuddy.org/trials/invictus-trial/2026-10-02 https://hemeoncbuddy.org/trials/ipss-m/2026-10-02 https://hemeoncbuddy.org/trials/iris-trial/2026-10-02 https://hemeoncbuddy.org/trials/isg-sts-1001/2026-10-02 https://hemeoncbuddy.org/trials/iskia/2026-10-02 https://hemeoncbuddy.org/trials/isrc-spinal-sbrt-guidelines/2026-10-02 https://hemeoncbuddy.org/trials/ita-trial/2026-10-02 https://hemeoncbuddy.org/trials/itacitinib-ptcy-haploidentical-hct/2026-10-02 https://hemeoncbuddy.org/trials/ivosidenib-idh1-mutated-mds/2026-10-02 https://hemeoncbuddy.org/trials/ivosidenib-r-r-aml-phase-1-2/2026-10-02 https://hemeoncbuddy.org/trials/izalontamab-brengitecan-iza-bren/2026-10-02 https://hemeoncbuddy.org/trials/j-alex/2026-10-02 https://hemeoncbuddy.org/trials/jackson-port-thymoma-ncdb/2026-10-02 https://hemeoncbuddy.org/trials/jackson-sbrt-meta-analysis/2026-10-02 https://hemeoncbuddy.org/trials/jagsi-z0011-axillary-field-analysis/2026-10-02 https://hemeoncbuddy.org/trials/jakarta-2/2026-10-02 https://hemeoncbuddy.org/trials/jakarta/2026-10-02 https://hemeoncbuddy.org/trials/japanese-glottic-cancer-trial-yamazaki-2006/2026-10-02 https://hemeoncbuddy.org/trials/javelin-bladder-100-trial/2026-10-02 https://hemeoncbuddy.org/trials/javelin-gastric-100/2026-10-02 https://hemeoncbuddy.org/trials/javelin-head-and-neck-100/2026-10-02 https://hemeoncbuddy.org/trials/javelin-merkel-200/2026-10-02 https://hemeoncbuddy.org/trials/javelin-renal-101-trial/2026-10-02 https://hemeoncbuddy.org/trials/jcog1008-cisplatin-q3wk-vs-q1wk/2026-10-02 https://hemeoncbuddy.org/trials/jcog1008-long-term-follow-up/2026-10-02 https://hemeoncbuddy.org/trials/jcog1403/2026-10-02 https://hemeoncbuddy.org/trials/jlgk0901/2026-10-02 https://hemeoncbuddy.org/trials/johns-hopkins-salvage-rt-retrospective-trock/2026-10-02 https://hemeoncbuddy.org/trials/joint-outcome-study/2026-10-02 https://hemeoncbuddy.org/trials/jrosg-99-1/2026-10-02 https://hemeoncbuddy.org/trials/juliet/2026-10-02 https://hemeoncbuddy.org/trials/jupiter-02/2026-10-02 https://hemeoncbuddy.org/trials/karmma-3/2026-10-02 https://hemeoncbuddy.org/trials/karmma/2026-10-02 https://hemeoncbuddy.org/trials/katherine/2026-10-02 https://hemeoncbuddy.org/trials/keilholz-dupuytren-s-rt/2026-10-02 https://hemeoncbuddy.org/trials/keloid-rt-bed-meta-analysis/2026-10-02 https://hemeoncbuddy.org/trials/keloid-rt-meta-analysis/2026-10-02 https://hemeoncbuddy.org/trials/keylynk-001-trial/2026-10-02 https://hemeoncbuddy.org/trials/keynote-006/2026-10-02 https://hemeoncbuddy.org/trials/keynote-017/2026-10-02 https://hemeoncbuddy.org/trials/keynote-024/2026-10-02 https://hemeoncbuddy.org/trials/keynote-029-trial-pembro-vs-low-ipi/2026-10-02 https://hemeoncbuddy.org/trials/keynote-040-trial/2026-10-02 https://hemeoncbuddy.org/trials/keynote-042/2026-10-02 https://hemeoncbuddy.org/trials/keynote-045/2026-10-02 https://hemeoncbuddy.org/trials/keynote-048/2026-10-02 https://hemeoncbuddy.org/trials/keynote-052/2026-10-02 https://hemeoncbuddy.org/trials/keynote-054-trial-eortc-1325/2026-10-02 https://hemeoncbuddy.org/trials/keynote-057/2026-10-02 https://hemeoncbuddy.org/trials/keynote-087/2026-10-02 https://hemeoncbuddy.org/trials/keynote-091-pearls/2026-10-02 https://hemeoncbuddy.org/trials/keynote-119/2026-10-02 https://hemeoncbuddy.org/trials/keynote-158/2026-10-02 https://hemeoncbuddy.org/trials/keynote-164/2026-10-02 https://hemeoncbuddy.org/trials/keynote-170/2026-10-02 https://hemeoncbuddy.org/trials/keynote-177/2026-10-02 https://hemeoncbuddy.org/trials/keynote-181-trial/2026-10-02 https://hemeoncbuddy.org/trials/keynote-189/2026-10-02 https://hemeoncbuddy.org/trials/keynote-204/2026-10-02 https://hemeoncbuddy.org/trials/keynote-224/2026-10-02 https://hemeoncbuddy.org/trials/keynote-240/2026-10-02 https://hemeoncbuddy.org/trials/keynote-355/2026-10-02 https://hemeoncbuddy.org/trials/keynote-407/2026-10-02 https://hemeoncbuddy.org/trials/keynote-412/2026-10-02 https://hemeoncbuddy.org/trials/keynote-426-trial/2026-10-02 https://hemeoncbuddy.org/trials/keynote-522/2026-10-02 https://hemeoncbuddy.org/trials/keynote-564-trial/2026-10-02 https://hemeoncbuddy.org/trials/keynote-564/2026-10-02 https://hemeoncbuddy.org/trials/keynote-585/2026-10-02 https://hemeoncbuddy.org/trials/keynote-590/2026-10-02 https://hemeoncbuddy.org/trials/keynote-604/2026-10-02 https://hemeoncbuddy.org/trials/keynote-629/2026-10-02 https://hemeoncbuddy.org/trials/keynote-671-trial-5-year-update/2026-10-02 https://hemeoncbuddy.org/trials/keynote-671-trial/2026-10-02 https://hemeoncbuddy.org/trials/keynote-689/2026-10-02 https://hemeoncbuddy.org/trials/keynote-716/2026-10-02 https://hemeoncbuddy.org/trials/keynote-775/2026-10-02 https://hemeoncbuddy.org/trials/keynote-789-trial/2026-10-02 https://hemeoncbuddy.org/trials/keynote-811-trial/2026-10-02 https://hemeoncbuddy.org/trials/keynote-826/2026-10-02 https://hemeoncbuddy.org/trials/keynote-859/2026-10-02 https://hemeoncbuddy.org/trials/keynote-966/2026-10-02 https://hemeoncbuddy.org/trials/keynote-a18/2026-10-02 https://hemeoncbuddy.org/trials/keynote-b15-ev-304/2026-10-02 https://hemeoncbuddy.org/trials/keynote-b61/2026-10-02 https://hemeoncbuddy.org/trials/kim-2013-pituitary-adenoma-fsrt/2026-10-02 https://hemeoncbuddy.org/trials/klotz-active-surveillance/2026-10-02 https://hemeoncbuddy.org/trials/koch-2001-bilateral-tonsillectomy-unknown-primary/2026-10-02 https://hemeoncbuddy.org/trials/komet-001/2026-10-02 https://hemeoncbuddy.org/trials/korea-nk-t-cell-lymphoma-ccrt-kim/2026-10-02 https://hemeoncbuddy.org/trials/krystal-1-crc/2026-10-02 https://hemeoncbuddy.org/trials/krystal-12/2026-10-02 https://hemeoncbuddy.org/trials/kundel-adjuvant-rt-thymoma/2026-10-02 https://hemeoncbuddy.org/trials/l-mind/2026-10-02 https://hemeoncbuddy.org/trials/l-plus-2/2026-10-02 https://hemeoncbuddy.org/trials/lacc/2026-10-02 https://hemeoncbuddy.org/trials/lacewing-trial/2026-10-02 https://hemeoncbuddy.org/trials/lap07/2026-10-02 https://hemeoncbuddy.org/trials/lapact/2026-10-02 https://hemeoncbuddy.org/trials/latitude-trial/2026-10-02 https://hemeoncbuddy.org/trials/launch-trial-len-tace-vs-len-alone-in-adv-hcc/2026-10-02 https://hemeoncbuddy.org/trials/laura-trial/2026-10-02 https://hemeoncbuddy.org/trials/lazzari-sbrt-oligometastatic-ovarian/2026-10-02 https://hemeoncbuddy.org/trials/leap-002/2026-10-02 https://hemeoncbuddy.org/trials/leap-012/2026-10-02 https://hemeoncbuddy.org/trials/len-vs-sora-trial/2026-10-02 https://hemeoncbuddy.org/trials/lenvatinib-trial/2026-10-02 https://hemeoncbuddy.org/trials/libretto-001-thyroid/2026-10-02 https://hemeoncbuddy.org/trials/libretto-001/2026-10-02 https://hemeoncbuddy.org/trials/libretto-431/2026-10-02 https://hemeoncbuddy.org/trials/libretto-432/2026-10-02 https://hemeoncbuddy.org/trials/limb-sparing-surgery-vs-amputation-in-sts-rosenberg/2026-10-02 https://hemeoncbuddy.org/trials/lin-3d-crt-vs-imrt-esophageal-cancer/2026-10-02 https://hemeoncbuddy.org/trials/linker-mm1/2026-10-02 https://hemeoncbuddy.org/trials/litespark-004/2026-10-02 https://hemeoncbuddy.org/trials/litespark-005/2026-10-02 https://hemeoncbuddy.org/trials/litespark-011-trial/2026-10-02 https://hemeoncbuddy.org/trials/litespark-022-trial/2026-10-02 https://hemeoncbuddy.org/trials/litespark-022/2026-10-02 https://hemeoncbuddy.org/trials/lms04-lms-04/2026-10-02 https://hemeoncbuddy.org/trials/lnh-98-5-gela/2026-10-02 https://hemeoncbuddy.org/trials/lotis-2/2026-10-02 https://hemeoncbuddy.org/trials/low-dose-ruxolitinib-gvhd-prophylaxis-in-haploidentical-hsct/2026-10-02 https://hemeoncbuddy.org/trials/low-dose-tsebt-for-erythrodermic-mf-sezary-morris/2026-10-02 https://hemeoncbuddy.org/trials/lurbinectedin-monotherapy-pm1183/2026-10-02 https://hemeoncbuddy.org/trials/lustre-trial/2026-10-02 https://hemeoncbuddy.org/trials/lux-lung-1-afatinib-after-progression-on-tki/2026-10-02 https://hemeoncbuddy.org/trials/ma-17r/2026-10-02 https://hemeoncbuddy.org/trials/ma-20/2026-10-02 https://hemeoncbuddy.org/trials/macdonald-study-int0116-swog-9008/2026-10-02 https://hemeoncbuddy.org/trials/mach-nc-mena-analysis/2026-10-02 https://hemeoncbuddy.org/trials/madani-2009-imrt-sinonasal-tumors/2026-10-02 https://hemeoncbuddy.org/trials/magellan/2026-10-02 https://hemeoncbuddy.org/trials/magic-m001/2026-10-02 https://hemeoncbuddy.org/trials/magic-trial/2026-10-02 https://hemeoncbuddy.org/trials/magnetismm-3/2026-10-02 https://hemeoncbuddy.org/trials/magnitude/2026-10-02 https://hemeoncbuddy.org/trials/magnolia/2026-10-02 https://hemeoncbuddy.org/trials/maia-trial-final-os/2026-10-02 https://hemeoncbuddy.org/trials/maia/2026-10-02 https://hemeoncbuddy.org/trials/majestec-1/2026-10-02 https://hemeoncbuddy.org/trials/majestec-9-trial/2026-10-02 https://hemeoncbuddy.org/trials/majic-pv/2026-10-02 https://hemeoncbuddy.org/trials/maniakas-2012-vs-microsurgery-vs-srt-meta-analysis/2026-10-02 https://hemeoncbuddy.org/trials/manifest-2/2026-10-02 https://hemeoncbuddy.org/trials/map-3/2026-10-02 https://hemeoncbuddy.org/trials/maps/2026-10-02 https://hemeoncbuddy.org/trials/marianne/2026-10-02 https://hemeoncbuddy.org/trials/mariner/2026-10-02 https://hemeoncbuddy.org/trials/mariposa-2-trial/2026-10-02 https://hemeoncbuddy.org/trials/mariposa-trial/2026-10-02 https://hemeoncbuddy.org/trials/master-trial/2026-10-02 https://hemeoncbuddy.org/trials/matrix-ielsg43-trial/2026-10-02 https://hemeoncbuddy.org/trials/matterhorn-trial/2026-10-02 https://hemeoncbuddy.org/trials/matterhorn/2026-10-02 https://hemeoncbuddy.org/trials/mavoric/2026-10-02 https://hemeoncbuddy.org/trials/md-anderson-dose-escalation/2026-10-02 https://hemeoncbuddy.org/trials/md-anderson-post-op-srs/2026-10-02 https://hemeoncbuddy.org/trials/md-anderson-srs-wbrt/2026-10-02 https://hemeoncbuddy.org/trials/mdacc-adjuvant-rt-for-melanoma-ln-metastases-ballo/2026-10-02 https://hemeoncbuddy.org/trials/mdacc-frank/2026-10-02 https://hemeoncbuddy.org/trials/mdacc-head-neck-merkel-cell-carcinoma-bishop/2026-10-02 https://hemeoncbuddy.org/trials/mdacc-imrt-mpm-toxicity/2026-10-02 https://hemeoncbuddy.org/trials/mdacc-low-dose-rt-for-pcbcl-akhtari/2026-10-02 https://hemeoncbuddy.org/trials/mdacc-phase-ii-proton-vs-imrt-esophageal/2026-10-02 https://hemeoncbuddy.org/trials/mdacc-r-chop-rt-limited-stage-dlbcl-phan/2026-10-02 https://hemeoncbuddy.org/trials/mdacc-solitary-plasmacytoma-reed/2026-10-02 https://hemeoncbuddy.org/trials/mds-003/2026-10-02 https://hemeoncbuddy.org/trials/mds-004/2026-10-02 https://hemeoncbuddy.org/trials/mdx010-20/2026-10-02 https://hemeoncbuddy.org/trials/medalist/2026-10-02 https://hemeoncbuddy.org/trials/mepolizumab-hes/2026-10-02 https://hemeoncbuddy.org/trials/meta-analysis-len-maintenance-post-auto-hct/2026-10-02 https://hemeoncbuddy.org/trials/meta-analysis-of-ai-vs-tam-in-early-breast-cancer/2026-10-02 https://hemeoncbuddy.org/trials/meta-analysis-tace-sbrt-vs-tace-for-hcc-huo/2026-10-02 https://hemeoncbuddy.org/trials/metagist-group-trial/2026-10-02 https://hemeoncbuddy.org/trials/meteor-trial/2026-10-02 https://hemeoncbuddy.org/trials/mezagitamab-in-itp/2026-10-02 https://hemeoncbuddy.org/trials/mgh-bladder-preservation-long-term-outcomes-efstathiou/2026-10-02 https://hemeoncbuddy.org/trials/mgh-proton-ependymoma/2026-10-02 https://hemeoncbuddy.org/trials/mgus-risk-stratification/2026-10-02 https://hemeoncbuddy.org/trials/midas/2026-10-02 https://hemeoncbuddy.org/trials/milan-trial/2026-10-02 https://hemeoncbuddy.org/trials/mindact/2026-10-02 https://hemeoncbuddy.org/trials/mini-hypercvd-inotuzumab-older-adult-all/2026-10-02 https://hemeoncbuddy.org/trials/mint-trial-chop-vs-r-chop/2026-10-02 https://hemeoncbuddy.org/trials/mirasol/2026-10-02 https://hemeoncbuddy.org/trials/mogamulizumab-atll/2026-10-02 https://hemeoncbuddy.org/trials/mohamed-2019-imrt-vs-3d-crt-t1-larynx/2026-10-02 https://hemeoncbuddy.org/trials/momentum/2026-10-02 https://hemeoncbuddy.org/trials/monaleesa-2/2026-10-02 https://hemeoncbuddy.org/trials/monaleesa-3/2026-10-02 https://hemeoncbuddy.org/trials/monaleesa-7/2026-10-02 https://hemeoncbuddy.org/trials/monarch-2/2026-10-02 https://hemeoncbuddy.org/trials/monarch-3/2026-10-02 https://hemeoncbuddy.org/trials/monarche/2026-10-02 https://hemeoncbuddy.org/trials/monumental-1/2026-10-02 https://hemeoncbuddy.org/trials/monumental-3-trial/2026-10-02 https://hemeoncbuddy.org/trials/moran-dcis-tumor-bed-boost-meta-analysis/2026-10-02 https://hemeoncbuddy.org/trials/mosaic-trial/2026-10-02 https://hemeoncbuddy.org/trials/mosunetuzumab-fl/2026-10-02 https://hemeoncbuddy.org/trials/motion/2026-10-02 https://hemeoncbuddy.org/trials/mountain-02-trial/2026-10-02 https://hemeoncbuddy.org/trials/mountaineer/2026-10-02 https://hemeoncbuddy.org/trials/moxie/2026-10-02 https://hemeoncbuddy.org/trials/mpact/2026-10-02 https://hemeoncbuddy.org/trials/mrc-te18-eortc-30942-seminoma/2026-10-02 https://hemeoncbuddy.org/trials/mrc-te19-eortc-30982-seminoma/2026-10-02 https://hemeoncbuddy.org/trials/mri-response-adapted-crt-markovina/2026-10-02 https://hemeoncbuddy.org/trials/mskcc-3d-crt-mesothelioma-technique/2026-10-02 https://hemeoncbuddy.org/trials/mskcc-gastric-malt-experience-schechter/2026-10-02 https://hemeoncbuddy.org/trials/mskcc-phase-ii-mesothelioma/2026-10-02 https://hemeoncbuddy.org/trials/mskcc-sequential-neoadjuvant-folfox/2026-10-02 https://hemeoncbuddy.org/trials/mskcc-watch-and-wait-retrospective/2026-10-02 https://hemeoncbuddy.org/trials/mslt-i/2026-10-02 https://hemeoncbuddy.org/trials/mslt-ii-trial/2026-10-02 https://hemeoncbuddy.org/trials/multi-institutional-salvage-rt-stephenson/2026-10-02 https://hemeoncbuddy.org/trials/multicenter-sp-rare-cancer-network-ozsahin/2026-10-02 https://hemeoncbuddy.org/trials/murano-trial-ven-r-vs-br/2026-10-02 https://hemeoncbuddy.org/trials/murano/2026-10-02 https://hemeoncbuddy.org/trials/murphy-total-neoadjuvant-therapy-brpc-lapc/2026-10-02 https://hemeoncbuddy.org/trials/myeloid-sarcoma-rt/2026-10-02 https://hemeoncbuddy.org/trials/myeloma-xi/2026-10-02 https://hemeoncbuddy.org/trials/mystic-trial-durva-tremelimumab/2026-10-02 https://hemeoncbuddy.org/trials/n0147/2026-10-02 https://hemeoncbuddy.org/trials/nadim-ii/2026-10-02 https://hemeoncbuddy.org/trials/nadim-trial/2026-10-02 https://hemeoncbuddy.org/trials/nadina/2026-10-02 https://hemeoncbuddy.org/trials/naos-trial/2026-10-02 https://hemeoncbuddy.org/trials/napoli-1-study/2026-10-02 https://hemeoncbuddy.org/trials/napoli-3/2026-10-02 https://hemeoncbuddy.org/trials/natalee/2026-10-02 https://hemeoncbuddy.org/trials/natron-trial-benralizumab/2026-10-02 https://hemeoncbuddy.org/trials/ncctg-rtog-ecog-low-vs-high-dose-rt/2026-10-02 https://hemeoncbuddy.org/trials/ncdb-adjuvant-rt-and-chemo-in-merkel-cell-carcinoma-bhatia/2026-10-02 https://hemeoncbuddy.org/trials/ncdb-chemo-rt/2026-10-02 https://hemeoncbuddy.org/trials/ncdb-creasman/2026-10-02 https://hemeoncbuddy.org/trials/ncdb-port-analysis/2026-10-02 https://hemeoncbuddy.org/trials/ncdb-rao/2026-10-02 https://hemeoncbuddy.org/trials/nci-mycosis-fungoides-rct-kaye/2026-10-02 https://hemeoncbuddy.org/trials/ncic-ctg-ma-27-trial/2026-10-02 https://hemeoncbuddy.org/trials/neadjuvant-dostarlimab-in-dmmr-larc/2026-10-02 https://hemeoncbuddy.org/trials/nej009-trial-gefitinib-chemo/2026-10-02 https://hemeoncbuddy.org/trials/neoadjuvant-mvac/2026-10-02 https://hemeoncbuddy.org/trials/neoart/2026-10-02 https://hemeoncbuddy.org/trials/neocarhp/2026-10-02 https://hemeoncbuddy.org/trials/neocrtec5010/2026-10-02 https://hemeoncbuddy.org/trials/neonax-trial/2026-10-02 https://hemeoncbuddy.org/trials/neosphere/2026-10-02 https://hemeoncbuddy.org/trials/neostar-trial/2026-10-02 https://hemeoncbuddy.org/trials/nepa-olanzapine-cinv-trial/2026-10-02 https://hemeoncbuddy.org/trials/netter-1-trial/2026-10-02 https://hemeoncbuddy.org/trials/netter-2/2026-10-02 https://hemeoncbuddy.org/trials/new-epoc-trial/2026-10-02 https://hemeoncbuddy.org/trials/ngan-short-course-vs-long-course-crt/2026-10-02 https://hemeoncbuddy.org/trials/niagara/2026-10-02 https://hemeoncbuddy.org/trials/niche-2/2026-10-02 https://hemeoncbuddy.org/trials/nigro-regiment/2026-10-02 https://hemeoncbuddy.org/trials/nivolumab-ccrt-ipilimumab-vs-durvalumab-in-stage-iii-nsclc/2026-10-02 https://hemeoncbuddy.org/trials/nlphl-ghsg-hd7-hd15/2026-10-02 https://hemeoncbuddy.org/trials/noa-04-long-term-update/2026-10-02 https://hemeoncbuddy.org/trials/noa-04/2026-10-02 https://hemeoncbuddy.org/trials/noa-09-ceteg/2026-10-02 https://hemeoncbuddy.org/trials/nordic-nec/2026-10-02 https://hemeoncbuddy.org/trials/nordic-trial/2026-10-02 https://hemeoncbuddy.org/trials/nova-engot-ov16/2026-10-02 https://hemeoncbuddy.org/trials/np30179/2026-10-02 https://hemeoncbuddy.org/trials/nrg-gog-279/2026-10-02 https://hemeoncbuddy.org/trials/nrg-gu005/2026-10-02 https://hemeoncbuddy.org/trials/nrg-gy018/2026-10-02 https://hemeoncbuddy.org/trials/nrg-hn002/2026-10-02 https://hemeoncbuddy.org/trials/nrg-oncology-rtog-0848/2026-10-02 https://hemeoncbuddy.org/trials/nrg-rtog-1005-concurrent-vs-sequential-boost-in-early-breast/2026-10-02 https://hemeoncbuddy.org/trials/nrg-rtog-1203/2026-10-02 https://hemeoncbuddy.org/trials/nsabp-b-04-trial/2026-10-02 https://hemeoncbuddy.org/trials/nsabp-b-06-trial/2026-10-02 https://hemeoncbuddy.org/trials/nsabp-b-33/2026-10-02 https://hemeoncbuddy.org/trials/nsabp-b-35/2026-10-02 https://hemeoncbuddy.org/trials/nsabp-b-59-gepardouze-trial/2026-10-02 https://hemeoncbuddy.org/trials/nsabp-b15-trial/2026-10-02 https://hemeoncbuddy.org/trials/nsabp-c-07/2026-10-02 https://hemeoncbuddy.org/trials/nsabp-c-08/2026-10-02 https://hemeoncbuddy.org/trials/nsabp-r-01-first-adj-chemo-in-larc/2026-10-02 https://hemeoncbuddy.org/trials/nsabp-r-04-trial/2026-10-02 https://hemeoncbuddy.org/trials/nsgo-9501-eortc-mango-pooled/2026-10-02 https://hemeoncbuddy.org/trials/nwhht-terhaard-2005/2026-10-02 https://hemeoncbuddy.org/trials/nwts-2/2026-10-02 https://hemeoncbuddy.org/trials/nwts-3/2026-10-02 https://hemeoncbuddy.org/trials/o-sullivan-2001-princess-margaret-ipsilateral-rt/2026-10-02 https://hemeoncbuddy.org/trials/oak/2026-10-02 https://hemeoncbuddy.org/trials/oceanic-stroke/2026-10-02 https://hemeoncbuddy.org/trials/oceans/2026-10-02 https://hemeoncbuddy.org/trials/ocular-rt-in-all/2026-10-02 https://hemeoncbuddy.org/trials/olie-itcc-082/2026-10-02 https://hemeoncbuddy.org/trials/oligometastatic-nsclc-lct/2026-10-02 https://hemeoncbuddy.org/trials/oligometastatic-nsclc-trial/2026-10-02 https://hemeoncbuddy.org/trials/olnes-2012-eltrombopag-saa/2026-10-02 https://hemeoncbuddy.org/trials/olutasidenib-phase-2-pivotal/2026-10-02 https://hemeoncbuddy.org/trials/olverembatinib-global-phase-1b/2026-10-02 https://hemeoncbuddy.org/trials/olympia-6-year-update/2026-10-02 https://hemeoncbuddy.org/trials/olympia/2026-10-02 https://hemeoncbuddy.org/trials/olympiad/2026-10-02 https://hemeoncbuddy.org/trials/ontime-rigosertib-negative/2026-10-02 https://hemeoncbuddy.org/trials/opacin-neo/2026-10-02 https://hemeoncbuddy.org/trials/opra-trial-tnt-vs-hx-controls/2026-10-02 https://hemeoncbuddy.org/trials/optic/2026-10-02 https://hemeoncbuddy.org/trials/optim/2026-10-02 https://hemeoncbuddy.org/trials/optimismm-trial/2026-10-02 https://hemeoncbuddy.org/trials/optitrop-lung05/2026-10-02 https://hemeoncbuddy.org/trials/orator/2026-10-02 https://hemeoncbuddy.org/trials/oriole/2026-10-02 https://hemeoncbuddy.org/trials/pace-b/2026-10-02 https://hemeoncbuddy.org/trials/pace/2026-10-02 https://hemeoncbuddy.org/trials/pacific/2026-10-02 https://hemeoncbuddy.org/trials/paclitaxel-oral-solution-vs-injection-2l-gastric-cancer/2026-10-02 https://hemeoncbuddy.org/trials/paclitaxel-vs-peg-doxorubicin-in-in-kaposi-sarcoma/2026-10-02 https://hemeoncbuddy.org/trials/palette/2026-10-02 https://hemeoncbuddy.org/trials/pallas/2026-10-02 https://hemeoncbuddy.org/trials/paloma-2/2026-10-02 https://hemeoncbuddy.org/trials/paloma-3-trial/2026-10-02 https://hemeoncbuddy.org/trials/paloma-3/2026-10-02 https://hemeoncbuddy.org/trials/panova-3/2026-10-02 https://hemeoncbuddy.org/trials/panther/2026-10-02 https://hemeoncbuddy.org/trials/paola-1/2026-10-02 https://hemeoncbuddy.org/trials/papillon-trial/2026-10-02 https://hemeoncbuddy.org/trials/papmet/2026-10-02 https://hemeoncbuddy.org/trials/paradigm-trial-aml/2026-10-02 https://hemeoncbuddy.org/trials/paradigm-trial/2026-10-02 https://hemeoncbuddy.org/trials/paradigm/2026-10-02 https://hemeoncbuddy.org/trials/patchell-escc-surgery-trial/2026-10-02 https://hemeoncbuddy.org/trials/patchell-ii/2026-10-02 https://hemeoncbuddy.org/trials/patina-palbociclib-her2-directed-endocrine/2026-10-02 https://hemeoncbuddy.org/trials/pci-meta-analysis/2026-10-02 https://hemeoncbuddy.org/trials/pcyc-1121-ibrutinib-mzl/2026-10-02 https://hemeoncbuddy.org/trials/peace-1/2026-10-02 https://hemeoncbuddy.org/trials/pearl-trial/2026-10-02 https://hemeoncbuddy.org/trials/pearly-trial/2026-10-02 https://hemeoncbuddy.org/trials/peg-doxorubicin-vs-abv-in-kaposi-sarcoma/2026-10-02 https://hemeoncbuddy.org/trials/pegasus/2026-10-02 https://hemeoncbuddy.org/trials/pembro-gvd-r-r-chl/2026-10-02 https://hemeoncbuddy.org/trials/penelope-b/2026-10-02 https://hemeoncbuddy.org/trials/periscope-ii/2026-10-02 https://hemeoncbuddy.org/trials/perseus/2026-10-02 https://hemeoncbuddy.org/trials/persist-1-trial-pacritinib-in-mf/2026-10-02 https://hemeoncbuddy.org/trials/persist-2-trial-pacritinib-in-2nd-l-mf/2026-10-02 https://hemeoncbuddy.org/trials/petacc-8/2026-10-02 https://hemeoncbuddy.org/trials/petal/2026-10-02 https://hemeoncbuddy.org/trials/petit2/2026-10-02 https://hemeoncbuddy.org/trials/peyronie-s-disease-rt/2026-10-02 https://hemeoncbuddy.org/trials/phallcon/2026-10-02 https://hemeoncbuddy.org/trials/phase-i-ii-sbrt-for-hcc-bujold/2026-10-02 https://hemeoncbuddy.org/trials/phase-ii-sbrt-after-tace-for-hcc-kang/2026-10-02 https://hemeoncbuddy.org/trials/phase-ii-tace-sbrt-for-hcc-takeda/2026-10-02 https://hemeoncbuddy.org/trials/phoenix/2026-10-02 https://hemeoncbuddy.org/trials/pilot/2026-10-02 https://hemeoncbuddy.org/trials/pines/2026-10-02 https://hemeoncbuddy.org/trials/pivotal/2026-10-02 https://hemeoncbuddy.org/trials/plasma-exchange-for-ttp/2026-10-02 https://hemeoncbuddy.org/trials/pod1um-303-interaact-2-final-os-analysis/2026-10-02 https://hemeoncbuddy.org/trials/pod1um-303/2026-10-02 https://hemeoncbuddy.org/trials/poet-trial/2026-10-02 https://hemeoncbuddy.org/trials/pog-8631-ccg-923/2026-10-02 https://hemeoncbuddy.org/trials/pog-9412/2026-10-02 https://hemeoncbuddy.org/trials/polargo-trial/2026-10-02 https://hemeoncbuddy.org/trials/polarix/2026-10-02 https://hemeoncbuddy.org/trials/polish-ii-study/2026-10-02 https://hemeoncbuddy.org/trials/polish-rectal-cancer-trial/2026-10-02 https://hemeoncbuddy.org/trials/pollock-2003-meningioma-srs-tumor-control/2026-10-02 https://hemeoncbuddy.org/trials/pollux-trial/2026-10-02 https://hemeoncbuddy.org/trials/polo-trial/2026-10-02 https://hemeoncbuddy.org/trials/portec-1/2026-10-02 https://hemeoncbuddy.org/trials/portec-2/2026-10-02 https://hemeoncbuddy.org/trials/portec-3/2026-10-02 https://hemeoncbuddy.org/trials/portec-4a/2026-10-02 https://hemeoncbuddy.org/trials/poseidon-trial/2026-10-02 https://hemeoncbuddy.org/trials/post-excision-keloid-rt/2026-10-02 https://hemeoncbuddy.org/trials/post-remission-cytarabine-trial/2026-10-02 https://hemeoncbuddy.org/trials/potomac/2026-10-02 https://hemeoncbuddy.org/trials/pre-op-vs-post-op-rt-in-extremity-sts-o-sullivan/2026-10-02 https://hemeoncbuddy.org/trials/precis/2026-10-02 https://hemeoncbuddy.org/trials/precision-t-orca-t/2026-10-02 https://hemeoncbuddy.org/trials/preop-vs-postop-chemo/2026-10-02 https://hemeoncbuddy.org/trials/preopanc/2026-10-02 https://hemeoncbuddy.org/trials/prevail-trial/2026-10-02 https://hemeoncbuddy.org/trials/prevent/2026-10-02 https://hemeoncbuddy.org/trials/prima-ovarian-first-line/2026-10-02 https://hemeoncbuddy.org/trials/prima/2026-10-02 https://hemeoncbuddy.org/trials/prime-trial/2026-10-02 https://hemeoncbuddy.org/trials/primo/2026-10-02 https://hemeoncbuddy.org/trials/prodige-12/2026-10-02 https://hemeoncbuddy.org/trials/prodige-24/2026-10-02 https://hemeoncbuddy.org/trials/prodige5-accord17/2026-10-02 https://hemeoncbuddy.org/trials/profile-1001-trial-crizotinib-in-ros1/2026-10-02 https://hemeoncbuddy.org/trials/profile-1014-trial-crizot-vs-chemo/2026-10-02 https://hemeoncbuddy.org/trials/profound/2026-10-02 https://hemeoncbuddy.org/trials/progression-after-1l-osimertinib-phase-1-2-trials/2026-10-02 https://hemeoncbuddy.org/trials/promid-trial-octreotide-vs-pbo/2026-10-02 https://hemeoncbuddy.org/trials/propel-ptcl/2026-10-02 https://hemeoncbuddy.org/trials/propel/2026-10-02 https://hemeoncbuddy.org/trials/proppr/2026-10-02 https://hemeoncbuddy.org/trials/prospect-trial/2026-10-02 https://hemeoncbuddy.org/trials/prosper/2026-10-02 https://hemeoncbuddy.org/trials/protect-trial/2026-10-02 https://hemeoncbuddy.org/trials/protect/2026-10-02 https://hemeoncbuddy.org/trials/proteus-trial/2026-10-02 https://hemeoncbuddy.org/trials/proton-pump-inhibitor-use-in-recurrent-glioblastoma/2026-10-02 https://hemeoncbuddy.org/trials/proton-rt-cost-effectiveness/2026-10-02 https://hemeoncbuddy.org/trials/proton-rt-quality-of-life-review/2026-10-02 https://hemeoncbuddy.org/trials/proton-vs-imrt-esophageal-cancer/2026-10-02 https://hemeoncbuddy.org/trials/proton-vs-photon-csi-medulloblastoma/2026-10-02 https://hemeoncbuddy.org/trials/proton-vs-photon-hcc-icc/2026-10-02 https://hemeoncbuddy.org/trials/proud-pv-and-continuation-pv-ropeg-vs-hu-in-pv/2026-10-02 https://hemeoncbuddy.org/trials/psmaddition-trial/2026-10-02 https://hemeoncbuddy.org/trials/psmafore/2026-10-02 https://hemeoncbuddy.org/trials/pt1/2026-10-02 https://hemeoncbuddy.org/trials/ptcy-ruxolitinib-vs-ptcy-tac-mmf-phase-2-noninferiority/2026-10-02 https://hemeoncbuddy.org/trials/quad-shot/2026-10-02 https://hemeoncbuddy.org/trials/quantum-first/2026-10-02 https://hemeoncbuddy.org/trials/quantum-r/2026-10-02 https://hemeoncbuddy.org/trials/quasar/2026-10-02 https://hemeoncbuddy.org/trials/quazar-trial-aza-maintenance/2026-10-02 https://hemeoncbuddy.org/trials/radiant-3/2026-10-02 https://hemeoncbuddy.org/trials/radiant-4-trial/2026-10-02 https://hemeoncbuddy.org/trials/radicals-hd/2026-10-02 https://hemeoncbuddy.org/trials/radicals-rt/2026-10-02 https://hemeoncbuddy.org/trials/raiha/2026-10-02 https://hemeoncbuddy.org/trials/rainbow/2026-10-02 https://hemeoncbuddy.org/trials/raise/2026-10-02 https://hemeoncbuddy.org/trials/rano-criteria/2026-10-02 https://hemeoncbuddy.org/trials/rapid-chl/2026-10-02 https://hemeoncbuddy.org/trials/rapid/2026-10-02 https://hemeoncbuddy.org/trials/rapido-trial/2026-10-02 https://hemeoncbuddy.org/trials/rasolute-302/2026-10-02 https://hemeoncbuddy.org/trials/rathl/2026-10-02 https://hemeoncbuddy.org/trials/ratify-calgb-10603-trial/2026-10-02 https://hemeoncbuddy.org/trials/rationale-302/2026-10-02 https://hemeoncbuddy.org/trials/rationale-309/2026-10-02 https://hemeoncbuddy.org/trials/raves/2026-10-02 https://hemeoncbuddy.org/trials/ray/2026-10-02 https://hemeoncbuddy.org/trials/rct-adjuvant-rt-vs-observation-in-stage-i-mcc-jouary/2026-10-02 https://hemeoncbuddy.org/trials/re-cover/2026-10-02 https://hemeoncbuddy.org/trials/re-ly/2026-10-02 https://hemeoncbuddy.org/trials/reach-2/2026-10-02 https://hemeoncbuddy.org/trials/reach-3-trial/2026-10-02 https://hemeoncbuddy.org/trials/reach1/2026-10-02 https://hemeoncbuddy.org/trials/reach2-trial/2026-10-02 https://hemeoncbuddy.org/trials/reach3/2026-10-02 https://hemeoncbuddy.org/trials/reach4/2026-10-02 https://hemeoncbuddy.org/trials/recourse/2026-10-02 https://hemeoncbuddy.org/trials/regard-trial/2026-10-02 https://hemeoncbuddy.org/trials/regorafenib-trial/2026-10-02 https://hemeoncbuddy.org/trials/rektum-iii-trial-cape-vs-5fu/2026-10-02 https://hemeoncbuddy.org/trials/relativity-047/2026-10-02 https://hemeoncbuddy.org/trials/relay-trial-erlotinib-ramucirumab/2026-10-02 https://hemeoncbuddy.org/trials/relaza-2/2026-10-02 https://hemeoncbuddy.org/trials/relevance/2026-10-02 https://hemeoncbuddy.org/trials/relight-trial/2026-10-02 https://hemeoncbuddy.org/trials/renoir-trial/2026-10-02 https://hemeoncbuddy.org/trials/rescue-trial-camrelizumab-apatinib/2026-10-02 https://hemeoncbuddy.org/trials/resonate-2/2026-10-02 https://hemeoncbuddy.org/trials/resonate-trial-ibrutinib-vs-ofa-in-rrcll/2026-10-02 https://hemeoncbuddy.org/trials/resorce-trial/2026-10-02 https://hemeoncbuddy.org/trials/resort-e4402/2026-10-02 https://hemeoncbuddy.org/trials/response-2/2026-10-02 https://hemeoncbuddy.org/trials/response/2026-10-02 https://hemeoncbuddy.org/trials/ret-fusion-pancreatic-cancer-kras-wt-repotrectinib-and-preci/2026-10-02 https://hemeoncbuddy.org/trials/retroembrace/2026-10-02 https://hemeoncbuddy.org/trials/reverse-ad/2026-10-02 https://hemeoncbuddy.org/trials/review-rt-for-extremity-soft-tissue-sarcoma-haas/2026-10-02 https://hemeoncbuddy.org/trials/ricover-60/2026-10-02 https://hemeoncbuddy.org/trials/ricover-north-dlbcl-consolidation-rt/2026-10-02 https://hemeoncbuddy.org/trials/rivaroxaban-vs-warfarin-in-aps-trial/2026-10-02 https://hemeoncbuddy.org/trials/ro-chop/2026-10-02 https://hemeoncbuddy.org/trials/roa-2004/2026-10-02 https://hemeoncbuddy.org/trials/roads/2026-10-02 https://hemeoncbuddy.org/trials/roam-eortc-1308/2026-10-02 https://hemeoncbuddy.org/trials/roar-atc/2026-10-02 https://hemeoncbuddy.org/trials/roar-hcl-cohort/2026-10-02 https://hemeoncbuddy.org/trials/robust/2026-10-02 https://hemeoncbuddy.org/trials/rocket-af-trial-rivaroxaban-vs-warfarin-in-afib/2026-10-02 https://hemeoncbuddy.org/trials/rockstar/2026-10-02 https://hemeoncbuddy.org/trials/romidepsin-ctcl/2026-10-02 https://hemeoncbuddy.org/trials/romidepsin-ptcl/2026-10-02 https://hemeoncbuddy.org/trials/romiplostim-for-cit/2026-10-02 https://hemeoncbuddy.org/trials/romiplostim-itp/2026-10-02 https://hemeoncbuddy.org/trials/rosella/2026-10-02 https://hemeoncbuddy.org/trials/rosewood/2026-10-02 https://hemeoncbuddy.org/trials/rt-before-tme-trial/2026-10-02 https://hemeoncbuddy.org/trials/rt-dose-and-volume-effects-on-relapse-in-mcc-foote/2026-10-02 https://hemeoncbuddy.org/trials/rt-for-axillary-melanoma-metastases-beadle-mdacc/2026-10-02 https://hemeoncbuddy.org/trials/rt-for-desmoplastic-melanoma-guadagnolo-mdacc/2026-10-02 https://hemeoncbuddy.org/trials/rt-for-epithelial-skin-cancer-dose-fractionation-locke/2026-10-02 https://hemeoncbuddy.org/trials/rt-in-non-bulky-limited-stage-dlbcl-lamy/2026-10-02 https://hemeoncbuddy.org/trials/rt-ipilimumab-in-metastatic-melanoma-hiniker-stanford/2026-10-02 https://hemeoncbuddy.org/trials/rtog-0129/2026-10-02 https://hemeoncbuddy.org/trials/rtog-0225/2026-10-02 https://hemeoncbuddy.org/trials/rtog-0236/2026-10-02 https://hemeoncbuddy.org/trials/rtog-0529/2026-10-02 https://hemeoncbuddy.org/trials/rtog-0539/2026-10-02 https://hemeoncbuddy.org/trials/rtog-0617/2026-10-02 https://hemeoncbuddy.org/trials/rtog-0631/2026-10-02 https://hemeoncbuddy.org/trials/rtog-0813/2026-10-02 https://hemeoncbuddy.org/trials/rtog-0825/2026-10-02 https://hemeoncbuddy.org/trials/rtog-1016/2026-10-02 https://hemeoncbuddy.org/trials/rtog-83-05-hypofractionation-vs-conventional-rt-for-melanoma/2026-10-02 https://hemeoncbuddy.org/trials/rtog-8501-crt-vs-rt-alone/2026-10-02 https://hemeoncbuddy.org/trials/rtog-89-02/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9001/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9111/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9310-primary-cns-lymphoma/2026-10-02 https://hemeoncbuddy.org/trials/rtog-94-08/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9402-idh-analysis/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9402-long-term/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9402/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9413-long-term-follow-up/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9413/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9501/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9508/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9514/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9601/2026-10-02 https://hemeoncbuddy.org/trials/rtog-97-14/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9704/2026-10-02 https://hemeoncbuddy.org/trials/rtog-98-04/2026-10-02 https://hemeoncbuddy.org/trials/rtog-98-11-trial-mitomycin-vs-cis/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9802/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9811-long-term/2026-10-02 https://hemeoncbuddy.org/trials/rtog-9904/2026-10-02 https://hemeoncbuddy.org/trials/rtog-anal-rectal-contouring-atlas/2026-10-02 https://hemeoncbuddy.org/trials/rtog-gtv-ctv-contouring-consensus-for-sts-wang/2026-10-02 https://hemeoncbuddy.org/trials/rtog-pooled-bladder-preserving-analysis-mak/2026-10-02 https://hemeoncbuddy.org/trials/rtog1010-trial-chemort-trastuzumab/2026-10-02 https://hemeoncbuddy.org/trials/ruby-reni-cel-in-scd/2026-10-02 https://hemeoncbuddy.org/trials/ruby/2026-10-02 https://hemeoncbuddy.org/trials/ruxolitinib-maintenance-after-allo-hct/2026-10-02 https://hemeoncbuddy.org/trials/rxponder/2026-10-02 https://hemeoncbuddy.org/trials/s-trac-trial/2026-10-02 https://hemeoncbuddy.org/trials/s1826/2026-10-02 https://hemeoncbuddy.org/trials/sabr-comet/2026-10-02 https://hemeoncbuddy.org/trials/saeed-2020-anaplastic-thyroid-cancer-crt/2026-10-02 https://hemeoncbuddy.org/trials/salvage-hypofractionated-rt-post-prostatectomy-bcr/2026-10-02 https://hemeoncbuddy.org/trials/sarc021-th-cr-406/2026-10-02 https://hemeoncbuddy.org/trials/sarode-2013-4f-pcc/2026-10-02 https://hemeoncbuddy.org/trials/sbrt-as-bridge-to-transplant-for-hcc-sapisochin/2026-10-02 https://hemeoncbuddy.org/trials/sbrt-for-cholangiocarcinoma-sandler/2026-10-02 https://hemeoncbuddy.org/trials/sbrt-for-primary-hcc-andolino/2026-10-02 https://hemeoncbuddy.org/trials/sbrt-phase-ii-multi-institutional-herman/2026-10-02 https://hemeoncbuddy.org/trials/sbrt-vs-rfa-for-hcc-wahl/2026-10-02 https://hemeoncbuddy.org/trials/scagliotti-trial/2026-10-02 https://hemeoncbuddy.org/trials/scheinberg-2011-horse-vs-rabbit-atg-saa/2026-10-02 https://hemeoncbuddy.org/trials/schram-am-et-al-nejm-2025-enrgy-trial/2026-10-02 https://hemeoncbuddy.org/trials/scot/2026-10-02 https://hemeoncbuddy.org/trials/sealand-trial-allg-mm23/2026-10-02 https://hemeoncbuddy.org/trials/second-primary-malignancy-risk-in-multiple-myeloma-cohort/2026-10-02 https://hemeoncbuddy.org/trials/seer-limited-stage-dlbcl-rt-analysis-odejide/2026-10-02 https://hemeoncbuddy.org/trials/seer-metastasectomy-analysis/2026-10-02 https://hemeoncbuddy.org/trials/seer-orton/2026-10-02 https://hemeoncbuddy.org/trials/select-d/2026-10-02 https://hemeoncbuddy.org/trials/select-trial-lenvatinib-2nd-line/2026-10-02 https://hemeoncbuddy.org/trials/senomac/2026-10-02 https://hemeoncbuddy.org/trials/sentinel-node-positivity-predictors-in-mcc-schwartz/2026-10-02 https://hemeoncbuddy.org/trials/sentry-trial/2026-10-02 https://hemeoncbuddy.org/trials/sequence-trial/2026-10-02 https://hemeoncbuddy.org/trials/sequoia/2026-10-02 https://hemeoncbuddy.org/trials/sexie/2026-10-02 https://hemeoncbuddy.org/trials/sfop-m4/2026-10-02 https://hemeoncbuddy.org/trials/sharp-trial-sora-vs-pbo/2026-10-02 https://hemeoncbuddy.org/trials/sheehan-2005-pituitary-adenoma-srs-meta-analysis/2026-10-02 https://hemeoncbuddy.org/trials/sheehan-2011-nonfunctioning-pituitary-adenoma-srs/2026-10-02 https://hemeoncbuddy.org/trials/sheehan-2013-cushing-s-disease-srs/2026-10-02 https://hemeoncbuddy.org/trials/shepherd/2026-10-02 https://hemeoncbuddy.org/trials/shine/2026-10-02 https://hemeoncbuddy.org/trials/shoushtari-2011-imrt-unknown-primary/2026-10-02 https://hemeoncbuddy.org/trials/simplify-1/2026-10-02 https://hemeoncbuddy.org/trials/singapore-sqnp01/2026-10-02 https://hemeoncbuddy.org/trials/sins/2026-10-02 https://hemeoncbuddy.org/trials/skyscraper-01-trial/2026-10-02 https://hemeoncbuddy.org/trials/skyscraper-03-trial/2026-10-02 https://hemeoncbuddy.org/trials/skyscraper-06-trial/2026-10-02 https://hemeoncbuddy.org/trials/skyscraper-07-trial/2026-10-02 https://hemeoncbuddy.org/trials/slotman-thoracic-rt-es-sclc/2026-10-02 https://hemeoncbuddy.org/trials/smith-astro-wbi-guideline/2026-10-02 https://hemeoncbuddy.org/trials/soft-trial/2026-10-02 https://hemeoncbuddy.org/trials/solar-1/2026-10-02 https://hemeoncbuddy.org/trials/solaris-alliance-a021703/2026-10-02 https://hemeoncbuddy.org/trials/sole-trial/2026-10-02 https://hemeoncbuddy.org/trials/solo-2/2026-10-02 https://hemeoncbuddy.org/trials/solo1/2026-10-02 https://hemeoncbuddy.org/trials/solo2/2026-10-02 https://hemeoncbuddy.org/trials/sonia-trial-cdk4-6i-timing-analysis/2026-10-02 https://hemeoncbuddy.org/trials/sonia-trial-ctdna-biomarker-analysis/2026-10-02 https://hemeoncbuddy.org/trials/sophia/2026-10-02 https://hemeoncbuddy.org/trials/sox-rt-after-d2-gastrectomy/2026-10-02 https://hemeoncbuddy.org/trials/spartan/2026-10-02 https://hemeoncbuddy.org/trials/spearhead-1/2026-10-02 https://hemeoncbuddy.org/trials/spinal-cord-compression-in-multiple-myeloma-rades/2026-10-02 https://hemeoncbuddy.org/trials/spinal-cord-radiosurgery/2026-10-02 https://hemeoncbuddy.org/trials/spine-sbrt-pain-outcomes/2026-10-02 https://hemeoncbuddy.org/trials/spinet/2026-10-02 https://hemeoncbuddy.org/trials/spirit-french/2026-10-02 https://hemeoncbuddy.org/trials/spirit/2026-10-02 https://hemeoncbuddy.org/trials/spotlight/2026-10-02 https://hemeoncbuddy.org/trials/spport-rtog-0534/2026-10-02 https://hemeoncbuddy.org/trials/squire-trial-gem-cis-necitumumab-in-sq-nsclc/2026-10-02 https://hemeoncbuddy.org/trials/srs-radiation-necrosis-predictors/2026-10-02 https://hemeoncbuddy.org/trials/srs-vs-wbrt-for-brain-metastases/2026-10-02 https://hemeoncbuddy.org/trials/ssg-xviii-trial/2026-10-02 https://hemeoncbuddy.org/trials/sso-astro-asco-margins-guideline-dcis/2026-10-02 https://hemeoncbuddy.org/trials/sso-astro-asco-margins-guideline-invasive-bc/2026-10-02 https://hemeoncbuddy.org/trials/st-jude-ependymoma-series/2026-10-02 https://hemeoncbuddy.org/trials/stage-iii-nsclc-immunotherapy-review-durvalumab-et-al/2026-10-02 https://hemeoncbuddy.org/trials/stamina/2026-10-02 https://hemeoncbuddy.org/trials/stamp-trial-pembrolizumab-in-merkel-cell-carcinoma/2026-10-02 https://hemeoncbuddy.org/trials/stampede-abi/2026-10-02 https://hemeoncbuddy.org/trials/stampede-doce/2026-10-02 https://hemeoncbuddy.org/trials/stampede-rt/2026-10-02 https://hemeoncbuddy.org/trials/stanford-tsebt-for-mycosis-fungoides-navi/2026-10-02 https://hemeoncbuddy.org/trials/star-p-2/2026-10-02 https://hemeoncbuddy.org/trials/star-trec-trial/2026-10-02 https://hemeoncbuddy.org/trials/starglo/2026-10-02 https://hemeoncbuddy.org/trials/stars-rosel/2026-10-02 https://hemeoncbuddy.org/trials/start-b/2026-10-02 https://hemeoncbuddy.org/trials/start-trial-iv-arginine-for-scd-pain/2026-10-02 https://hemeoncbuddy.org/trials/stellar-303/2026-10-02 https://hemeoncbuddy.org/trials/stellar/2026-10-02 https://hemeoncbuddy.org/trials/stil-trial/2026-10-02 https://hemeoncbuddy.org/trials/stim/2026-10-02 https://hemeoncbuddy.org/trials/stimulus-mds1/2026-10-02 https://hemeoncbuddy.org/trials/stockholm-iii/2026-10-02 https://hemeoncbuddy.org/trials/stomp/2026-10-02 https://hemeoncbuddy.org/trials/stop-2/2026-10-02 https://hemeoncbuddy.org/trials/stop/2026-10-02 https://hemeoncbuddy.org/trials/storm-mm/2026-10-02 https://hemeoncbuddy.org/trials/storm/2026-10-02 https://hemeoncbuddy.org/trials/strass-eortc-62092/2026-10-02 https://hemeoncbuddy.org/trials/study-19/2026-10-02 https://hemeoncbuddy.org/trials/stupp/2026-10-02 https://hemeoncbuddy.org/trials/su2c-sarc032/2026-10-02 https://hemeoncbuddy.org/trials/subito-trial/2026-10-02 https://hemeoncbuddy.org/trials/successor-2-trial/2026-10-02 https://hemeoncbuddy.org/trials/summit-trial/2026-10-02 https://hemeoncbuddy.org/trials/sun-2016/2026-10-02 https://hemeoncbuddy.org/trials/sunitinib-net-sun-vs-pbo/2026-10-02 https://hemeoncbuddy.org/trials/sunitinib-trial/2026-10-02 https://hemeoncbuddy.org/trials/sunitinib-versus-inf-alfa/2026-10-02 https://hemeoncbuddy.org/trials/sunlight/2026-10-02 https://hemeoncbuddy.org/trials/supremo-trial-10-year-analysis/2026-10-02 https://hemeoncbuddy.org/trials/surpass-et/2026-10-02 https://hemeoncbuddy.org/trials/surveillance-in-m-rcc/2026-10-02 https://hemeoncbuddy.org/trials/sustain/2026-10-02 https://hemeoncbuddy.org/trials/suzuki-2015-mutational-landscape-lgg/2026-10-02 https://hemeoncbuddy.org/trials/swedish-rectal-cancer-trial/2026-10-02 https://hemeoncbuddy.org/trials/swog-1505-trial/2026-10-02 https://hemeoncbuddy.org/trials/swog-8794/2026-10-02 https://hemeoncbuddy.org/trials/swog-nrg-s1914-trial/2026-10-02 https://hemeoncbuddy.org/trials/swog-s0016-15-year/2026-10-02 https://hemeoncbuddy.org/trials/swog-s0777-trial/2026-10-02 https://hemeoncbuddy.org/trials/swog-s0809-adjuvant-crt-for-ecca-gbc/2026-10-02 https://hemeoncbuddy.org/trials/swog-s1801/2026-10-02 https://hemeoncbuddy.org/trials/sympatico-final-analysis/2026-10-02 https://hemeoncbuddy.org/trials/sympatico/2026-10-02 https://hemeoncbuddy.org/trials/tace-sbrt-for-hcc-kubo/2026-10-02 https://hemeoncbuddy.org/trials/tace-sbrt-vs-sorafenib-for-hcc-with-pvtt-yoon/2026-10-02 https://hemeoncbuddy.org/trials/taghian-nsabp-lrf-analysis/2026-10-02 https://hemeoncbuddy.org/trials/tags/2026-10-02 https://hemeoncbuddy.org/trials/tailor-x/2026-10-02 https://hemeoncbuddy.org/trials/tailorx/2026-10-02 https://hemeoncbuddy.org/trials/taishan-302-tambotatug-pelitecan-vs-topotecan-2l-sclc/2026-10-02 https://hemeoncbuddy.org/trials/takahashi-her2-sdc/2026-10-02 https://hemeoncbuddy.org/trials/takahashi-pci-vs-observation/2026-10-02 https://hemeoncbuddy.org/trials/talapro-2/2026-10-02 https://hemeoncbuddy.org/trials/talapro-3/2026-10-02 https://hemeoncbuddy.org/trials/talentop-trial/2026-10-02 https://hemeoncbuddy.org/trials/tax-323-trial-tpf-vs-pf-induction/2026-10-02 https://hemeoncbuddy.org/trials/tax-324-trial-tpf-vs-pf-induction/2026-10-02 https://hemeoncbuddy.org/trials/tax-327/2026-10-02 https://hemeoncbuddy.org/trials/tazemetostat-epithelioid-sarcoma/2026-10-02 https://hemeoncbuddy.org/trials/tazemetostat-fl/2026-10-02 https://hemeoncbuddy.org/trials/tbcrc-048-olaparib-expanded/2026-10-02 https://hemeoncbuddy.org/trials/tcga-endometrial-analysis/2026-10-02 https://hemeoncbuddy.org/trials/team-trial/2026-10-02 https://hemeoncbuddy.org/trials/tebentafusp-5-year-os-imcgp100-202/2026-10-02 https://hemeoncbuddy.org/trials/tebentafusp-in-metastatic-uveal-melanoma/2026-10-02 https://hemeoncbuddy.org/trials/teclistamab-daratumumab/2026-10-02 https://hemeoncbuddy.org/trials/telestar/2026-10-02 https://hemeoncbuddy.org/trials/temozolomide-in-advanced-leiomyosarcoma-immunotherapy-sensit/2026-10-02 https://hemeoncbuddy.org/trials/temsirolimus-vs-inf-alfa-trial/2026-10-02 https://hemeoncbuddy.org/trials/testicular-rt-in-all/2026-10-02 https://hemeoncbuddy.org/trials/text-soft/2026-10-02 https://hemeoncbuddy.org/trials/text-trail/2026-10-02 https://hemeoncbuddy.org/trials/therap-trial/2026-10-02 https://hemeoncbuddy.org/trials/thor/2026-10-02 https://hemeoncbuddy.org/trials/titan-trial-ttp/2026-10-02 https://hemeoncbuddy.org/trials/titan-trial/2026-10-02 https://hemeoncbuddy.org/trials/tivo-3/2026-10-02 https://hemeoncbuddy.org/trials/tme-trial/2026-10-02 https://hemeoncbuddy.org/trials/tnt-trial/2026-10-02 https://hemeoncbuddy.org/trials/tntcrt-trial/2026-10-02 https://hemeoncbuddy.org/trials/toga/2026-10-02 https://hemeoncbuddy.org/trials/top-trial-osi-chemo-vs-osi-egfr-tp53-co-mutated-nsclc/2026-10-02 https://hemeoncbuddy.org/trials/top-trial/2026-10-02 https://hemeoncbuddy.org/trials/topaz-1/2026-10-02 https://hemeoncbuddy.org/trials/torch/2026-10-02 https://hemeoncbuddy.org/trials/tosca/2026-10-02 https://hemeoncbuddy.org/trials/total-therapy-xv/2026-10-02 https://hemeoncbuddy.org/trials/tourmaline-mm1/2026-10-02 https://hemeoncbuddy.org/trials/tower-blinatumab-trial/2026-10-02 https://hemeoncbuddy.org/trials/townsley-2016/2026-10-02 https://hemeoncbuddy.org/trials/townsley-2017-saa-eltrombopag/2026-10-02 https://hemeoncbuddy.org/trials/tpc-vs-pf-induction-la-npc/2026-10-02 https://hemeoncbuddy.org/trials/trabectedin-vs-dacarbazine-in-liposarcoma/2026-10-02 https://hemeoncbuddy.org/trials/transcend-cll-004/2026-10-02 https://hemeoncbuddy.org/trials/transcend-fl/2026-10-02 https://hemeoncbuddy.org/trials/transcend-nhl-001/2026-10-02 https://hemeoncbuddy.org/trials/transform-1-trial/2026-10-02 https://hemeoncbuddy.org/trials/transform/2026-10-02 https://hemeoncbuddy.org/trials/traps-trail-rivaroxaban-vs-warfarin-in-high-risk-apls/2026-10-02 https://hemeoncbuddy.org/trials/trastuzumab-botidotin-vs-t-dm1-her2-mbc/2026-10-02 https://hemeoncbuddy.org/trials/treat/2026-10-02 https://hemeoncbuddy.org/trials/treosulfan-flu-ebmt/2026-10-02 https://hemeoncbuddy.org/trials/triangle-4-5-year-update/2026-10-02 https://hemeoncbuddy.org/trials/triangle/2026-10-02 https://hemeoncbuddy.org/trials/tribe-2-trial/2026-10-02 https://hemeoncbuddy.org/trials/tribe/2026-10-02 https://hemeoncbuddy.org/trials/tricc/2026-10-02 https://hemeoncbuddy.org/trials/trics-iii/2026-10-02 https://hemeoncbuddy.org/trials/trident-1/2026-10-02 https://hemeoncbuddy.org/trials/triplete-trial/2026-10-02 https://hemeoncbuddy.org/trials/triss/2026-10-02 https://hemeoncbuddy.org/trials/triton3-trial-rucaparib-mcrpc-triton3/2026-10-02 https://hemeoncbuddy.org/trials/triumph/2026-10-02 https://hemeoncbuddy.org/trials/trog-01-04/2026-10-02 https://hemeoncbuddy.org/trials/trog-03-04-radar/2026-10-02 https://hemeoncbuddy.org/trials/trog-05-01-post-op-crt-vs-rt-for-high-risk-cscc-h-n-porceddu/2026-10-02 https://hemeoncbuddy.org/trials/trog-99-03/2026-10-02 https://hemeoncbuddy.org/trials/trop2-adcs-in-nsclc-clinical-overview/2026-10-02 https://hemeoncbuddy.org/trials/trop2-targeted-adcs-in-nsclc-expert-consensus-2026-edition/2026-10-02 https://hemeoncbuddy.org/trials/trophy-u-01/2026-10-02 https://hemeoncbuddy.org/trials/tropics-02/2026-10-02 https://hemeoncbuddy.org/trials/tropion-breast01/2026-10-02 https://hemeoncbuddy.org/trials/tropion-breast02-trial/2026-10-02 https://hemeoncbuddy.org/trials/tropion-lung-01-dato-dxd-in-2l-nsclc/2026-10-02 https://hemeoncbuddy.org/trials/tropion-lung05/2026-10-02 https://hemeoncbuddy.org/trials/tucidinostat-r-chop/2026-10-02 https://hemeoncbuddy.org/trials/twitch/2026-10-02 https://hemeoncbuddy.org/trials/two-trimodality-techniques-bladder-preservation-zapatero/2026-10-02 https://hemeoncbuddy.org/trials/ucla-city-of-hope/2026-10-02 https://hemeoncbuddy.org/trials/ucsf-acc-series/2026-10-02 https://hemeoncbuddy.org/trials/ucsf-cn0-parotid-series/2026-10-02 https://hemeoncbuddy.org/trials/uf-acc-series-mendenhall-2004/2026-10-02 https://hemeoncbuddy.org/trials/uk-rapid/2026-10-02 https://hemeoncbuddy.org/trials/ukall-2003/2026-10-02 https://hemeoncbuddy.org/trials/ukccr-anal-cancer-trial/2026-10-02 https://hemeoncbuddy.org/trials/ukw-3/2026-10-02 https://hemeoncbuddy.org/trials/unicancer-prodige-23/2026-10-02 https://hemeoncbuddy.org/trials/university-of-toronto-sbrt-phase-i-hcc-icca/2026-10-02 https://hemeoncbuddy.org/trials/us-intergroup-trial-swog0033-clagb1501105/2026-10-02 https://hemeoncbuddy.org/trials/usortc-9735-trial/2026-10-02 https://hemeoncbuddy.org/trials/va-larynx-study/2026-10-02 https://hemeoncbuddy.org/trials/valentine-ptcl01/2026-10-02 https://hemeoncbuddy.org/trials/velia/2026-10-02 https://hemeoncbuddy.org/trials/vemurafenib-rituximab-hcl/2026-10-02 https://hemeoncbuddy.org/trials/venetoclax-obinutuzumab-hcl-hclv/2026-10-02 https://hemeoncbuddy.org/trials/vesper-trial-perioperative-dd-mvac-vs-gemcis-in-mibc/2026-10-02 https://hemeoncbuddy.org/trials/viale-a/2026-10-02 https://hemeoncbuddy.org/trials/viale-c/2026-10-02 https://hemeoncbuddy.org/trials/vision-trial/2026-10-02 https://hemeoncbuddy.org/trials/vorinostat-ctcl/2026-10-02 https://hemeoncbuddy.org/trials/voyager/2026-10-02 https://hemeoncbuddy.org/trials/warfasa/2026-10-02 https://hemeoncbuddy.org/trials/watch-and-wait-meta-analysis-renehan/2026-10-02 https://hemeoncbuddy.org/trials/wbrt-prognostic-score/2026-10-02 https://hemeoncbuddy.org/trials/wilkins-chhip-dose-constraints/2026-10-02 https://hemeoncbuddy.org/trials/window-1/2026-10-02 https://hemeoncbuddy.org/trials/wjog9717l7-trial-osi-ramucirumab/2026-10-02 https://hemeoncbuddy.org/trials/woman/2026-10-02 https://hemeoncbuddy.org/trials/wu-esophageal-imrt-contouring-guidelines/2026-10-02 https://hemeoncbuddy.org/trials/wu-kong28-trial/2026-10-02 https://hemeoncbuddy.org/trials/wu-kong6-sunvozertinib-dzd9008/2026-10-02 https://hemeoncbuddy.org/trials/yale-primary-cutaneous-b-cell-lymphoma-smith/2026-10-02 https://hemeoncbuddy.org/trials/zeal-1l-trial/2026-10-02 https://hemeoncbuddy.org/trials/zeta/2026-10-02 https://hemeoncbuddy.org/trials/zhang-2019-induction-gc-crt-npc/2026-10-02 https://hemeoncbuddy.org/trials/zips-2-trial-zinc-for-infection-prevention-in-sca/2026-10-02 https://hemeoncbuddy.org/trials/zuma-1/2026-10-02 https://hemeoncbuddy.org/trials/zuma-12/2026-10-02 https://hemeoncbuddy.org/trials/zuma-2/2026-10-02 https://hemeoncbuddy.org/trials/zuma-3/2026-10-02 https://hemeoncbuddy.org/trials/zuma-5/2026-10-02 https://hemeoncbuddy.org/trials/zuma-7-axicabtagene-ciloleucel-as-second-line-therapy-for-la/2026-10-02